The role of mitochondria in the pathogenesis of type 2 diabetes
Open accessAbstract
The pathophysiology of type 2 diabetes mellitus (DM) is varied and complex.However, the association of DM with obesity and inactivity indicates an important, and potentially pathogenic, link between fuel and energy homeostasis and the emergence of metabolic disease.Given the central role for mitochondria in fuel utilization and energy production, disordered mitochondrial function at the cellular level can impact whole-body metabolic homeostasis.Thus, the hypothesis that defective or insufficient mitochondrial function might play a potentially pathogenic role in mediating risk of type 2 DM has emerged in recent years.Here, we summarize current literature on risk factors for diabetes pathogenesis, on the specific role(s) of mitochondria in tissues involved in its pathophysiology, and on evidence pointing to alterations in mitochondrial function in these tissues that could contribute to the development of DM.We also review literature on metabolic phenotypes of existing animal models of impaired mitochondrial function.We conclude that, whereas the association between impaired mitochondrial function and DM is strong, a causal pathogenic relationship remains uncertain.However, we hypothesize that genetically determined and/or inactivity-mediated alterations in mitochondrial oxidative activity may directly impact adaptive responses to overnutrition, causing an imbalance between oxidative activity and nutrient load.This imbalance may lead in turn to chronic accumulation of lipid oxidative metabolites that can mediate insulin resistance and secretory dysfunction.More refined experimental strategies that accurately mimic potential reductions in mitochondrial functional capacity in humans at risk for diabetes will be required to determine the potential pathogenic role in human insulin resistance and type 2 DM.(Endocrine Reviews 31: 364 -395, 2010) I. Type 2 Diabetes Pathogenesis A. Risk factors associated with type 2 diabetes II.General Overview of Mitochondrial Biology A. The dynamic morphology of mitochondria B. Mechanisms that control mitochondrial density and capacity III.Role of Mitochondria in Tissue-Specific Contexts A. Muscle B. Adipose tissue C. Liver D. Pancreatic -cells IV.Experimental Strategies to Explore the Relationship between Mitochondrial Function and DM A. PGC-1 ␣ and  overexpression B. PGC-1 knockout models C. Other mitochondrial function defects V. Conclusions I. Type 2 Diabetes Pathogenesis T ype 2 diabetes mellitus (DM) in the United States and around the world has reached epidemic proportions.At present, 17.9 million people in the United States have been diagnosed with diabetes, with an additional 5.7 million undiagnosed (1).Together, this encompasses 8% of the population, and thus, diabetes is a major public health issue.In addition, current data indicate that 57 million Americans suffer from prediabetes (defined as fasting blood glucose between 100 and 125 mg/dl) (1).Diabetes disproportionately affects specific ethnic populations, with risk increased 1.8-fold in African-Americans, 1.7fold in Mexican-Americans, and 2.2-fold in Native Amer-
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that impaired mitochondrial oxidative function is strongly associated with type 2 diabetes but that a causal pathogenic relationship remains uncertain. It hypothesizes that genetically determined and/or inactivity-mediated reductions in mitochondrial oxidative activity can create an imbalance between oxidative capacity and nutrient load, promoting lipid metabolite accumulation, insulin resistance, and secretory dysfunction.
Key findings
- In skeletal muscle, OXPHOS complex I activity was reduced by about 40% in type 2 DM and by 20% in obese individuals; these differences did not remain after normalization for mitochondrial mass, suggesting reduced mitochondrial mass is a major contributor.
- In offspring of type 2 diabetic subjects, 31P spectroscopy showed fasting mitochondrial OXPHOS rates reduced by 30%, TCA cycle flux reduced by 30%, and muscle mitochondrial density 38% lower; insulin-stimulated ATP synthesis was reduced by more than 90% in nonobese first-degree relatives.
- OXPHOS mRNA expression was reduced by 20–30% in humans with type 2 DM, and muscle PGC-1α and PGC-1β mRNA were reduced by nearly 50% in diabetes; however, oxidative dysfunction was not observed in all insulin-resistant individuals.
- Mouse models with PGC-1α or PGC-1β deficiency or other mitochondrial defects often showed normal or enhanced insulin sensitivity, leading the authors to conclude that absolute mitochondrial deficiency alone does not directly produce insulin resistance.
Methods
- Design: narrative review and critical synthesis of published literature on mitochondrial function in type 2 diabetes pathogenesis.
- Data/sample: human studies of muscle, adipose tissue, liver, and pancreatic β-cells, plus animal models including PGC-1α/β transgenic and knockout mice and other mitochondrial function defects.
- Main analysis: qualitative integration of evidence across tissues and experimental models, with summary tables of PGC-1 transgenic and knockout phenotypes; no systematic review, meta-analysis, or new primary data are reported.
Limitations
- Stated: current human data are insufficient to determine whether impaired oxidative capacity causes insulin resistance or results from it; animal data are limited by interspecies comparisons and difficulty recapitulating subtle human mitochondrial changes and gene–fuel-load interactions.
- Stated: serial liver biopsies in humans are unlikely to be performed, limiting longitudinal tests of the proposed hepatic hypothesis.
- Evident from the text: as a narrative review, it does not use a systematic search strategy or formal quality appraisal, and the cited human studies vary by population, obesity, fitness, ethnicity, and tissue, which the authors note may explain discordant findings.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 353 cited sources checked · 0 supported · 0 flagged
- Findingcitation
ADP and succinate-stimulated oxygen consumption is modestly reduced in permeabilized muscle fibers from obese individuals with type 2 DM.
“Similarly, Boushel et al. (115) found modest reductions in ADP and succinate-stimulated oxygen consumption in permeabilized muscle fibers from obese individuals with type 2 DM.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [115] Boushel, 2007, Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle., Diabetologia source
Not checked in the free run.
- Interpretationreasoning
The imbalance between oxidative activity and nutrient load may lead to chronic accumulation of lipid oxidative metabolites that can mediate insulin resistance and secretory dysfunction.
“This imbalance may lead in turn to chronic accumulation of lipid oxidative metabolites that can mediate insulin resistance and secretory dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
Insulin resistance is common in high-risk individuals years before the onset of type 2 DM.
“Several longitudinal studies have indicated that insulin resistance, measured as reduced insulin-stimulated glucose disposal during the hyperinsulinemic euglycemic clamp or by iv glucose tolerance testing, is common in high-risk individuals years before the onset of type 2 DM (27)(28)(29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (27)(28)(29)
Not checked in the free run.
- Premisecitation
Oxidative activity (e.g., citrate synthase, acyl CoA dehydrogenase) is a robust correlate of insulin sensitivity, even better than intramyocellular triglycerides or long-chain fatty acyl CoA.
“Moreover, oxidative activity (e.g., citrate synthase, acyl CoA dehydrogenase) is a robust correlate of insulin sensitivity, even better than either im triglycerides or long-chain fatty acyl CoA (110).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Bruce, 2003, Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status., J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Global gene expression analysis demonstrated a 20-30% reduction in mRNA expression levels for multiple nuclear-encoded genes of the OXPHOS pathway in humans with type 2 DM.
“Analysis of global gene expression patterns has also demonstrated a 20 -30% reduction in mRNA expression levels for multiple nuclear-encoded genes of the OXPHOS pathway in humans with type 2 DM (121-123).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [121] Mootha, 2003, PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes., Nat Genet source
Not checked in the free run.
- cites [122] Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [123] Sreekumar, 2002, Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment., Diabetes source
Not checked in the free run.
- Premisecitation
Several conditions associated with susceptibility to insulin resistance, including obesity, lipid accumulation, and aging, have all been associated with reduced nuclear-encoded OXPHOS gene expression.
“Several conditions associated with susceptibility to insulin resistance, including obesity, lipid accumulation, and aging, have all been associated with reduced nuclearencoded OXPHOS gene expression.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
- cites [128] Sparks, 2005, A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle., Diabetes source
Not checked in the free run.
- cites [129] Richardson, 2005, Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle., J Biol Chem source
Not checked in the free run.
- Premisecitation
Reduced OXPHOS gene expression has been observed in response to short-term high-fat feeding, even in humans.
“Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity (127), short-term high-fat feeding (even in humans) (128), lipid infusion (129), and lipid loading of myotubes (127).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [128] Sparks, 2005, A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle., Diabetes source
Not checked in the free run.
- Premisecitation
In Asian Indian subjects, there is no correlation between changes in OXPHOS gene expression and insulin resistance.
“Interestingly, a recent study of Asian Indian subjects found no correlation between changes in OXPHOS gene expression and insulin resistance (125).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Nair, 2008, Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance., Diabetes source
Not checked in the free run.
- Interpretationcitation
Defects in lipid oxidation in DM can be significant contributors to disordered oxidative metabolism even in the absence of detectable alterations in OXPHOS gene expression or function.
“Thus, defects in lipid oxidation in DM can be significant contributors to disordered oxidative metabolism even in the absence of detectable alterations in OXPHOS gene expression or function.”
Quote in the paperSubstantial claim - Premisecitation
Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity.
“Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity (127), short-term high-fat feeding (even in humans) (128), lipid infusion (129), and lipid loading of myotubes (127).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
- Interpretationreasoning
One possible mechanism by which impaired mitochondrial function might contribute to insulin resistance is via altered metabolism of fatty acids.
“Thus, one possible mechanism by which impaired mitochondrial function might contribute to insulin resistance is via altered metabolism of fatty acids.”
Quote in the paperSubstantial claim - Interpretationreasoning
Inability to appropriately modulate oxidative function in response to the prevailing energetic environment is a signature of insulin resistance and diabetes risk.
“Because these short-term experimental protocols (several hours in duration at most) would not be expected to alter mitochondrial density, DNA content, or number, these data strongly suggest that inability to appropriately modulate oxidative function in response to the prevailing energetic environment is a signature of insulin resistance and diabetes risk.”
Quote in the paperSubstantial claim - Premisecitation
Similar reductions in OXPHOS gene expression have been observed in some, but not all, populations of insulin-resistant, but completely normoglycemic, individuals.
“Importantly, similar reductions in OXPHOS gene expression have been observed in some, but not all, populations of insulin-resistant, but completely normoglycemic, individuals (122, 124).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [122] Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [124] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents., J Clin Invest source
Not checked in the free run.
- Premisecitation
Electron microscopy demonstrates diminished mitochondrial size in obesity and diabetes, particularly in subsarcolemmal fractions.
“This possibility is consistent with electron microscopy demonstrating diminished mitochondrial size in obesity and diabetes (116), particularly in subsarcolemmal fractions (114).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Circulating triglycerides were significantly elevated in both nondiabetic and diabetic individuals of Asian Indian origin.
“However, circulating triglycerides were significantly elevated in both nondiabetic and diabetic individuals of Asian Indian origin (125).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] Nair, 2008, Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance., Diabetes source
Not checked in the free run.
- Premisecitation
Oxidative dysfunction is not observed in all insulin resistant individuals.
“First, oxidative dysfunction is not observed in all insulin resistant individuals (125).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] Nair, 2008, Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance., Diabetes source
Not checked in the free run.
- Premisecitation
In rats bred for low aerobic capacity over multiple generations, expression of several OXPHOS genes is markedly reduced, even in the absence of obesity.
“Similarly, in rats bred for low aerobic capacity over multiple generations, expression of several OXPHOS genes is markedly reduced, even in the absence of obesity (134).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [134] Wisløff, 2005, Cardiovascular risk factors emerge after artificial selection for low aerobic capacity., Science source
Not checked in the free run.
- Premisecitation
Aging is linked to impaired oxidative function in parallel with reductions in OXPHOS gene expression, including COX7A1, NDUFB6, and ATP50.
“Aging is also linked to impaired oxidative function (140) in parallel with reductions in OXPHOS gene expression, including COX7A1, NDUFB6, and ATP50 (136 -138).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [140] Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance., Science source
Not checked in the free run.
- cites [136] Rönn, 2008, Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle., Diabetologia source
Not checked in the free run.
- cites [137] Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins., J Clin Invest source
Not checked in the free run.
- cites [138] Rönn, 2009, Genetic variation in ATP5O is associated with skeletal muscle ATP50 mRNA expression and glucose uptake in young twins, PLoS ONE source
Not checked in the free run.
- Interpretationcitation
Genetic and epigenetic modifications may also contribute to reduced expression of OXPHOS genes in type 2 DM.
“Genetic and epigenetic modifications may also contribute to reduced expression of OXPHOS genes in type 2 DM.”
Quote in the paperNot a substantial claim - Premisecitation
Expression of COX7A1, a complex IV gene down-regulated in type 2 DM, is heritable (50-72% heritability, as assessed by analysis in monozygotic and dizygotic twins), indicating a strong genetic or shared familial environmental contribution.
“For example, expression of COX7A1, a complex IV gene down-regulated in type 2 DM, is heritable (50 -72% heritability, as assessed by analysis in monozygotic and dizygotic twins), indicating a strong genetic or shared familial environmental contribution (136).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] Rönn, 2008, Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle., Diabetologia source
Not checked in the free run.
- Premisecitation
Reductions in OXPHOS gene expression in patients with established type 2 DM can be partially normalized by insulin treatment.
“Reductions in OXPHOS gene expression in patients with established type 2 DM can be partially normalized by insulin treatment (123).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Sreekumar, 2002, Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment., Diabetes source
Not checked in the free run.
- Premisecitation
Relatively short-term reductions in serum fatty acids and intracellular fatty acyl CoA levels mediated by acipimox treatment in healthy humans are associated with reduced expression of nuclear-encoded mitochondrial oxidative genes in parallel with enhanced insulin sensitivity.
“Similarly, relatively short-term reductions in serum fatty acids and intracellular fatty acyl CoA levels mediated by acipimox treatment in healthy humans are associated with reduced expression of nuclear-encoded mitochondrial oxidative genes-in parallel with enhanced insulin sensitivity (294).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [294] Bajaj, 2007, Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentration., Diabetes source
Not checked in the free run.
- Premisecitation
In humans, maximal oxygen uptake is robustly correlated with OXPHOS gene expression.
“In humans, maximal oxygen uptake is robustly correlated with OXPHOS gene expression (133).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Parikh, 2008, Molecular correlates for maximal oxygen uptake and type 1 fibers, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Reduced OXPHOS gene expression has been observed in response to lipid loading of myotubes.
“Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity (127), short-term high-fat feeding (even in humans) (128), lipid infusion (129), and lipid loading of myotubes (127).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
- Premisecitation
Similar patterns are observed for the complex I gene NDUFB6 and the ATP synthase component ATP5O.
“Similar patterns are observed for the complex I gene NDUFB6 (137) and the ATP synthase component ATP5O (138).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [137] Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins., J Clin Invest source
Not checked in the free run.
- cites [138] Rönn, 2009, Genetic variation in ATP5O is associated with skeletal muscle ATP50 mRNA expression and glucose uptake in young twins, PLoS ONE source
Not checked in the free run.
- Premisecitation
Withdrawal of insulin in individuals with type 1 diabetes reduces muscle OXPHOS gene expression and ATP production rates.
“Similarly, withdrawal of insulin in individuals with type 1 diabetes reduces muscle OXPHOS gene expression and ATP production rates (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] Karakelides, 2007, Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects., Diabetes source
Not checked in the free run.
- Premisecitation
Reduced OXPHOS gene expression has been observed in response to lipid infusion.
“Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity (127), short-term high-fat feeding (even in humans) (128), lipid infusion (129), and lipid loading of myotubes (127).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Richardson, 2005, Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle., J Biol Chem source
Not checked in the free run.
- Premisecitation
Epigenetic mechanisms may also contribute to these patterns because reduced expression parallels increased DNA methylation of both the COX7A1 promoter and NDUFB6.
“Interestingly, epigenetic mechanisms may also contribute to these patterns because reduced expression parallels increased DNA methylation of both the COX7A1 promoter (136) and NDUFB6 (137, 139).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [136] Rönn, 2008, Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle., Diabetologia source
Not checked in the free run.
- cites [137] Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins., J Clin Invest source
Not checked in the free run.
- cites [139] Ling, 2009, Epigenetics: a molecular link between environmental factors and type 2 diabetes., Diabetes source
Not checked in the free run.
- Interpretationreasoning
Several lines of evidence suggest that the association between insulin resistance and skeletal muscle mitochondrial alterations may not be a causal relationship in all situations.
“However, several lines of evidence suggest that this may not be a causal relationship in all situations.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mediators of mitochondrial biogenesis, including ERRα, may contribute to the strong heritability of OXPHOS components.
“Mediators of mitochondrial biogenesis, including ERR␣, may contribute to the strong heritability of OXPHOS components.”
Quote in the paperNot a substantial claim - Premisecitation
These responses are not observed in all studies of high-fat feeding.
“However, these responses are not observed in all studies of high-fat feeding; in fact, some studies demonstrate that high-fat feeding is associated with increased numbers of mitochondrial protein and DNA content, potentially mediated by chronic fatty acid activation of PPAR nuclear receptors (130 -132).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [130] Garcia-Roves, 2007, Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [131] Hancock, 2008, High-fat diets cause insulin resistance despite an increase in muscle mitochondria., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [132] Sreekumar, 2002, Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Reduced physical fitness is associated with reduced muscle OXPHOS gene expression.
“Reduced physical fitness is associated with reduced muscle OXPHOS gene expression.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Parikh, 2008, Molecular correlates for maximal oxygen uptake and type 1 fibers, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- Premisenone given
Insulin resistance has been associated with alterations in skeletal muscle mitochondrial oxidative function and its transcriptional regulatory pathways.
“In summary, insulin resistance has been associated with alterations in skeletal muscle mitochondrial oxidative function and its transcriptional regulatory pathways.”
Quote in the paperSubstantial claim - Premisecitation
Saturated fatty acids reduce PGC-1α promoter transcriptional activity and expression in cultured myotubes, in parallel with reduced OXPHOS expression and O2 consumption.
“For example, saturated fatty acids reduce PGC-1␣ promoter transcriptional activity and expression in cultured myotubes, in parallel with reduced OXPHOS expression and O 2 consumption (127).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
- Premisecitation
Such depots appear to be less active as a function of aging and/or obesity.
“Such depots appear to be less active as a function of aging and/or obesity (151, 164 -167).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [151] Cypess, 2009, Identification and importance of brown adipose tissue in adult humans., N Engl J Med source
Not checked in the free run.
- cites [164] Saito, 2009, High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity., Diabetes source
Not checked in the free run.
- cites [165] Lichtenbelt, 2009, Cold-activated brown adipose tissue in healthy men., N Engl J Med source
Not checked in the free run.
- cites [166] Virtanen, 2009, Functional brown adipose tissue in healthy adults., N Engl J Med source
Not checked in the free run.
- cites [167] Zingaretti, 2009, The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue., FASEB J source
Not checked in the free run.
- Interpretationcitation
In the absence of mechanisms to ensure continuously elevated fuel oxidation, such as those present in brown fat, uncoupling of white adipose tissue mitochondria may decrease ATP levels and impair anabolic flux.
“These results suggest that, in the absence of mechanisms to ensure continuously elevated fuel oxidation, such as those present in brown fat, uncoupling of white adipose tissue mitochondria may decrease ATP levels and impair anabolic flux (183).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Rossmeisl, 2004, Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores, Int J Obes Relat Metab Disord source
Not checked in the free run.
- Premisecitation
UCP1 expression in adipocytes driven by the aP2 promoter failed to significantly raise resting metabolic rate.
“However, UCP1 expression in adipocytes driven by the aP2 promoter failed to significantly raise resting metabolic rate (185).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [185] Stefl, 1998, Brown fat is essential for cold-induced thermogenesis but not for obesity resistance in aP2-Ucp mice, Am J Physiol
Not checked in the free run.
- Premisecitation
A recent compendium of mitochondrial proteins from 14 different mouse tissues indicates that white adipocyte mitochondria contain a more diverse protein repertoire than mitochondria from heart, skeletal muscle, or brain.
“Interestingly, a recent compendium of mitochondrial proteins from 14 different mouse tissues indicates that white adipocyte mitochondria contain a more diverse protein repertoire than mitochondria from heart, skeletal muscle, or brain (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Pagliarini, 2008, A mitochondrial protein compendium elucidates complex I disease biology., Cell source
Not checked in the free run.
- Premisecitation
In cultured adipocytes, ectopic expression of UCP1 impairs fatty acid synthesis.
“Moreover, in cultured adipocytes, ectopic expression of UCP1 impairs fatty acid synthesis (186, 187).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [186] Rossmeisl, 2000, Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue, FASEB J source
Not checked in the free run.
- cites [187] Si, 2007, Effects of forced uncoupling protein 1 expression in 3T3–L1 cells on mitochondrial function and lipid metabolism., J Lipid Res source
Not checked in the free run.
- Interpretationcitation
Decreased mitochondrial capacity in adipocytes may also alter adipocyte insulin sensitivity and/or function due to the high energetic requirements for fatty acid storage, adipokine secretion, insulin signaling, and glucose uptake.
“In addition to effects on fuel utilization, decreased mitochondrial capacity in adipocytes may also alter adipocyte insulin sensitivity and/or function due to the high energetic requirements for fatty acid storage, adipokine secretion (160), insulin signaling (161), and glucose uptake.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [160] Koh, 2007, Essential role of mitochondrial function in adiponectin synthesis in adipocytes., Diabetes source
Not checked in the free run.
- cites [161] Shi, 2008, Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells., J Biol Chem source
Not checked in the free run.
- Premisecitation
Gain-of-function studies in mice where ectopic expression of UCPs mitigate diet-induced obesity support the notion that uncoupling could be sufficient.
“Gain-of-function studies in mice where ectopic expression of UCPs mitigate diet-induced obesity support the notion that uncoupling could be sufficient (183, 184).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [183] Rossmeisl, 2004, Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores, Int J Obes Relat Metab Disord source
Not checked in the free run.
- cites [184] Harper, 2001, Mitochondrial uncoupling as a target for drug development for the treatment of obesity., Obes Rev source
Not checked in the free run.
- Premisecitation
In brown adipose tissue, electron transport is greatly accelerated due to tissue-specific expression of the mitochondrial UCP1.
“In this tissue, electron transport is greatly accelerated due to tissue-specific expression of the mitochondrial UCP1.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [150] Cannon, 1985, The biochemistry of an inefficient tissue: brown adipose tissue., Essays Biochem
Not checked in the free run.
- cites [153] Bouillaud, 1985, Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [154] Jacobsson, 1985, Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression., J Biol Chem source
Not checked in the free run.
- cites [155] Ricquier, 1997, The mitochondrial uncoupling protein: structural and genetic studies., Prog Nucleic Acid Res Mol Biol source
Not checked in the free run.
- Interpretationcitation
Oxidative capacity is not likely to be limiting in the resting state in muscle.
“Second, oxidative activity is determined by the need to generate energy to meet cellular demands, e.g., contraction and ion transport; thus oxidative capacity is not likely to be limiting in the resting state in muscle (3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Holloszy, 2009, Skeletal muscle “mitochondrial deficiency” does not mediate insulin resistance., Am J Clin Nutr source
Not checked in the free run.
- Interpretationcitation
White adipocyte mitochondria appear to be equipped for a broader array of functions compared with mitochondria in tissues that must sustain rapid bursts of energy-requiring processes.
“Thus, white adipocyte mitochondria appear to be equipped for a broader array of functions compared with mitochondria in tissues that must sustain rapid bursts of energy-requiring processes.”
Quote in the paperNot a substantial claim - Interpretationreasoning
UCP1-mediated uncoupling alone cannot fully account for the large thermogenic capacity of brown adipocytes in the absence of mechanisms that ensure continuous substrate delivery to the ETC.
“UCP1-mediated uncoupling alone, however, cannot fully account for the large thermogenic capacity of brown adipocytes in the absence of mechanisms that ensure continuous substrate delivery to the ETC.”
Quote in the paperNot a substantial claim - Interpretationcitation
The apparent paradoxical result of high insulin sensitivity despite deficiency in lipid storage in Fsp27-deficient mice appears to be due to increased mitochondrial density and activity in white adipocytes, which are brown-like in their increased capacity to oxidize large quantities of fatty acids.
“This apparent paradoxical result (high insulin sensitivity despite deficiency in lipid storage), appears to be due to the increased mitochondrial density and activity in white adipocytes, which are brown-like in their increased capacity to oxidize large quantities of fatty acids.”
Quote in the paperNot a substantial claim - Premisecitation
Mice with adipose tissue-specific ablation of the insulin receptor (FIRKO mice) display high levels of mitochondrial genes involved in fatty acid oxidation and OXPHOS over the lifespan of the animals.
“For example, mice with adipose tissue-specific ablation of the insulin receptor (FIRKO mice) display high levels of mitochondrial genes involved in fatty acid oxidation and OXPHOS over the lifespan of the animals (201).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [201] Katic, 2007, Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice., Aging Cell source
Not checked in the free run.
- Premisecitation
The genetic program leading to brown adipose tissue development, and potentially to the high abundance of mitochondria, is initiated by the zinc-finger protein PRDM16.
“The genetic program leading to brown adipose tissue development, and potentially to the high abundance of mitochondria, is initiated by the zinc-finger protein PRDM16 (202)(203)(204).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [202] Seale, 2007, Transcriptional control of brown fat determination by PRDM16., Cell Metab source
Not checked in the free run.
- cites [203] Seale, 2008, PRDM16 controls a brown fat/skeletal muscle switch., Nature source
Not checked in the free run.
- cites [204] Timmons, 2007, Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages., Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
Administration of thiazolidinediones induces changes in mitochondrial content and remodeling in white adipocytes concomitantly with an improvement in insulin sensitivity.
“Administration of thiazolidinediones induces changes in mitochondrial content and remodeling in white adipocytes concomitantly with an improvement in insulin sensitivity (170, 173, 177, 190, 194 -198).”
Quote in the paperSubstantial claim0 of 9 sources checked- cites [170] Bogacka, 2005, Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo., Diabetes source
Not checked in the free run.
- cites [173] Orci, 2004, Rapid transformation of white adipocytes into fat-oxidizing machines., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [177] Wilson-Fritch, 2004, Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone., J Clin Invest source
Not checked in the free run.
- cites [190] Rong, 2007, Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone., Diabetes source
Not checked in the free run.
- cites [194] Boden, 2005, Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients., Diabetes source
Not checked in the free run.
- cites [195] Bogacka, 2005, Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro., J Clin Endocrinol Metab source
Not checked in the free run.
- cites [196] Digby, 1998, Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes., Diabetes source
Not checked in the free run.
- cites [197] Goetzman, 2009, The regulation of acyl-CoA dehydrogenases in adipose tissue by rosiglitazone., Obesity (Silver Spring) source
Not checked in the free run.
- cites [198] Laplante, 2006, Mechanisms of the depot specificity of peroxisome proliferator-activated receptor γ action on adipose tissue metabolism., Diabetes source
Not checked in the free run.
- Premisecitation
Expression of nuclear-encoded OXPHOS genes is down-regulated in visceral adipose tissue of humans with type 2 DM.
“In parallel, expression of nuclear-encoded OXPHOS genes is down-regulated in visceral adipose tissue of humans with type 2 DM (193).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [193] Dahlman, 2006, Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-α., Diabetes source
Not checked in the free run.
- Premisecitation
Recent human data have highlighted the importance of disordered hepatic metabolism, including inappropriately increased hepatic glucose production, hyperlipidemia, and lipid accumulation, in both obesity and type 2 DM.
“Recent human data have highlighted the importance of disordered hepatic metabolism, including inappropriately increased hepatic glucose production, hyperlipidemia, and lipid accumulation, in both obesity and type 2 DM (207).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [207] Kotronen, 2008, Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome., Diabetologia source
Not checked in the free run.
- Premisecitation
Patterns of gene expression are distinct in liver.
“Similarly, patterns of gene expression are distinct in liver (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Mootha, 2003, Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria., Cell source
Not checked in the free run.
- Premisecitation
Nitric oxide production by the endothelial nitric oxide synthase has also been linked to enhanced adipose tissue mitochondrial biogenesis and prevention of high-fat diet-induced obesity.
“Nitric oxide production by the endothelial nitric oxide synthase has also been linked to enhanced adipose tissue mitochondrial biogenesis and prevention of high-fat dietinduced obesity (200).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] Tedesco, 2008, Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes., Diabetes source
Not checked in the free run.
- Premisecitation
In cultured adipocytes, impairment of respiratory chain function through depletion of Tfam during adipocyte differentiation results in impaired insulin-stimulated glucose transport.
“Interestingly, in cultured adipocytes, impairment of respiratory chain function through depletion of Tfam during adipocyte differentiation results in impaired insulinstimulated glucose transport (161); data in animal models are necessary to determine the physiological relevance of this finding.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Shi, 2008, Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells., J Biol Chem source
Not checked in the free run.
- Premisecitation
Hepatic lipid accumulation may result when adipose lipid storage capacity is exceeded, as in obesity or adipocyte dysfunction (e.g., lipodystrophy).
“Hepatic lipid accumulation may result when adipose lipid storage capacity is exceeded, as in obesity or adipocyte dysfunction (e.g., lipodystrophy) (213).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [213] Agarwal, 2006, Genetic disorders of adipose tissue development, differentiation, and death., Annu Rev Genomics Hum Genet source
Not checked in the free run.
- Interpretationreasoning
Increased ROS related to increased fatty acid oxidation and/or hyperglycemia might contribute to up-regulation of OXPHOS gene expression in coexisting obesity and type 2 DM.
“Thus, increased ROS related to increased fatty acid oxidation and/or hyperglycemia might contribute to up-regulation of OXPHOS gene expression in coexisting obesity and type 2 DM.”
Quote in the paperSubstantial claim - Interpretationcitation
Up-regulation of PGC-1β in this context may contribute to increased gluconeogenesis and hyperlipidemia, in part via coactivation of sterol regulatory element binding transcription factor 1, as observed in high-fat diet-fed mice.
“Up-regulation of PGC-1 in this context may contribute to increased gluconeogenesis and hyperlipidemia, in part via coactivation of sterol regulatory element binding transcription factor 1, as observed in high-fat diet-fed mice (223).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] Lin, 2003, PGC-1β in the regulation of hepatic glucose and energy metabolism., J Biol Chem source
Not checked in the free run.
- Premisecitation
Recent application of 31P NMR to the liver in humans demonstrates that rates of ATP synthesis are 3-fold higher in liver than in muscle.
“Recent application of 31 P NMR to the liver in humans demonstrates that rates of ATP synthesis are 3-fold higher in liver than in muscle (212).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [212] Schmid, 2008, Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment., NMR Biomed source
Not checked in the free run.
- Interpretationnone given
Available data indicate that hepatic lipid accumulation and insulin resistance are intimately linked with mitochondrial oxidative dysfunction.
“In summary, available data indicate that hepatic lipid accumulation and insulin resistance are intimately linked with mitochondrial oxidative dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
Studies in Japanese individuals with established DM and modest obesity (BMI 27 kg/m2) observed a modestly increased expression of multiple genes within all complexes of OXPHOS complexes, in parallel with BMI and insulin resistance (measured by HOMA-IR).
“In contrast, studies in Japanese individuals with established DM and modest obesity (BMI 27 kg/m 2 ) observed a modestly increased expression of multiple genes within all complexes of OXPHOS complexes, in parallel with BMI and insulin resistance (measured by homeostasis model assessment of insulin resistance, HOMA-IR) (231).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [231] Takamura, 2008, Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients., Obesity (Silver Spring) source
Not checked in the free run.
- Interpretationcitation
Hepatic insulin resistance can cause mitochondrial dysfunction, at least in mice.
“However, more broadly, these data indicate that hepatic insulin resistance can cause mitochondrial dysfunction, at least in mice.”
Quote in the paperSubstantial claim - Premisecitation
Modest weight loss (about 8 kg) normalizes intrahepatic lipid in subjects with type 2 DM, in parallel with normalization of hepatic insulin sensitivity, even in the absence of changes in intramyocellular lipid accumulation or circulating adipocytokines.
“Conversely, modest weight loss (about 8 kg) normalizes intrahepatic lipid in subjects with type 2 DM, in parallel with normalization of hepatic insulin sensitivity, even in the absence of changes in intramyocellular lipid accumulation or circulating adipocytokines (215).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [215] Petersen, 2005, Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes., Diabetes source
Not checked in the free run.
- Interpretationcitation
Normal insulin signaling, which inhibits Foxo1, is required for maintenance of normal mitochondrial function in this model.
“These data indicate that normal insulin signaling, which inhibits Foxo1, is required for maintenance of normal mitochondrial function in this model.”
Quote in the paperSubstantial claim - Premisecitation
These effects in the liver appear to be mediated via reduced expression of the insulin receptor.
“These effects in the liver appear to be mediated via reduced expression of the insulin receptor (221).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [221] Ruddock, 2008, Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling., J Biochem source
Not checked in the free run.
- Premisecitation
Hepatic lipid accumulation is a robust predictor of not only hepatic, but also muscle and adipose insulin sensitivity, better than intraabdominal fat, body mass index (BMI), or other obesity measures.
“Interestingly, hepatic lipid accumulation is also a robust predictor of not only hepatic, but also muscle and adipose insulin sensitivity [better than intraabdominal fat, body mass index (BMI), or other obesity measures] (217, 218).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [217] Hwang, 2007, Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [218] Korenblat, 2008, Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects., Gastroenterology source
Not checked in the free run.
- Premisecitation
Mitochondrial dysfunction was reversed by deletion of Foxo1.
“Mitochondrial dysfunction was reversed by deletion of Foxo1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Cheng, 2009, Foxo1 integrates insulin signaling with mitochondrial function in the liver., Nat Med source
Not checked in the free run.
- Premisecitation
NASH is characterized by prominent abnormalities in mitochondrial ultrastructure, with increased size, loss of cristae, and paracrystalline inclusion bodies similar to those observed in some mitochondrial myopathies.
“Moreover, NASH is characterized by prominent abnormalities in mitochondrial ultrastructure, with increased size, loss of cristae, and paracrystalline inclusion bodies similar to those observed in some mitochondrial myopathies (235).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [235] Sanyal, 2001, Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities., Gastroenterology source
Not checked in the free run.
- Premisecitation
Circulating β-hydroxybutyrate levels are increased in NASH.
“Similarly, circulating -hydroxybutyrate levels are increased in NASH (235).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [235] Sanyal, 2001, Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities., Gastroenterology source
Not checked in the free run.
- Premisecitation
Incubation of hepatocytes with saturated long-chain fatty acids induces insulin resistance by reducing insulin-stimulated tyrosine phosphorylation of the insulin receptor and its downstream substrates.
“At a cellular level, incubation of hepatocytes with saturated long-chain fatty acids induces insulin resistance by reducing insulin-stimulated tyrosine phosphorylation of the insulin receptor and its downstream substrates (220, 221).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [220] Nakamura, 2009, Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria., J Biol Chem source
Not checked in the free run.
- cites [221] Ruddock, 2008, Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling., J Biochem source
Not checked in the free run.
- Interpretationreasoning
These data suggest excessive, but incomplete, fatty acid oxidation, potentially limited by reduced availability of NAD+ and FAD.
“Together, these data suggest excessive, but incomplete, fatty acid oxidation, potentially limited by reduced availability of NADϩ and FAD.”
Quote in the paperSubstantial claim - Premisecitation
Similar patterns were observed in obese subjects with established type 2 DM.
“Similar patterns were observed in obese subjects with established type 2 DM.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [232] Pihlajamäki, 2009, Thyroid hormone-related regulation of gene expression in human fatty liver., J Clin Endocrinol Metab source
Not checked in the free run.
- Interpretationreasoning
Mitochondrial diabetes is more likely to result from a gradual deterioration of β-cell function than from an acute functional impairment due to insufficient ATP production.
“These data suggest that mitochondrial diabetes is more likely to result from a gradual deterioration of -cell function, rather than from an acute functional impairment due to insufficient ATP production (246).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Maassen, 2004, Mitochondrial diabetes: molecular mechanisms and clinical presentation, Diabetes source
Not checked in the free run.
- Premisecitation
In a pure C57BL6/J background, UCP2 knockout accelerates β-cell failure and diabetes.
“In a mixed background, UCP2 knockout improves glycemic control in ob/ob mice (258), whereas in a pure C57BL6/J background, UCP2 knockout accelerates -cell failure and diabetes (259).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [259] Pi, 2009, Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic β-cell function., Endocrinology source
Not checked in the free run.
- Interpretationreasoning
Decreased ATP production due to unbalanced activation of UCPs by direct actions of fatty acids and their derivatives, in addition to excessive ROS, could underlie the accumulation of β-cell damage that precedes type 2 DM.
“It is likely that decreased ATP production due to unbalanced activation of UCPs by direct actions of fatty acids and their derivatives, in addition to excessive ROS, could underlie the accumulation of -cell damage that precedes type 2 DM (Fig. 4).”
Quote in the paperSubstantial claim - Premisecitation
The 3243A>G mutation in the mtDNA-encoded tRNALeu, UUR gene is associated with maternally inherited diabetes and deafness (MIDD).
“Of these, the best studied is the 3243AϾG mutation in the mtDNA-encoded tRNALeu, UUR gene, which is associated with maternally inherited diabetes and deafness (MIDD) (243,244).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [243] Kadowaki, 1994, A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA., N Engl J Med source
Not checked in the free run.
- cites [244] Maassen, 2006, New insights in the molecular pathogenesis of the maternally inherited diabetes and deafness syndrome., Endocrinol Metab Clin North Am source
Not checked in the free run.
- Premisecitation
Tfam has recently been shown to be directly downstream of PDX1, a key transcription factor for β-cell development.
“Moreover, Tfam has recently been shown to be directly downstream of PDX1, a key transcription factor for -cell development (242).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [242] Gauthier, 2009, PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression., Cell Metab source
Not checked in the free run.
- Interpretationreasoning
Excessive uncoupling due to excess FFA compromises ATP synthesis enough to impair insulin secretion and β-cell fitness.
“Thus, uncoupling occurs to an excessive degree, compromising ATP synthesis enough to impair insulin secretion and -cell fitness.”
Quote in the paperSubstantial claim - Interpretationreasoning
The delicate balance in which UCP2 is desirable for β-cell protection but undesirable for glycemic control probably underlies the discrepancy in results between two reports on the phenotype of UCP2 knockout mice.
“This delicate balance in which UCP2 is desirable for -cell protection, but undesirable for glycemic control, probably underlies the discrepancy in results between two reports on the phenotype of UCP2 knockout mice.”
Quote in the paperNot a substantial claim - Premisecitation
PGC-1α and related coactivators are critical for the regulation of mitochondrial oxidative capacity.
“PGC-1␣ and related coactivators are critical for the regulation of mitochondrial oxidative capacity, as demonstrated by the approximately 2-fold increases in mtDNA and oxygen consumption and a 50% increase in mitochondrial density in myotubes overexpressing PGC-1␣ (56).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1., Cell source
Not checked in the free run.
- Premisecitation
Subsequent recruitment of granules to the plasma membrane (second phase) appears to depend on mitochondrial metabolites produced by anaplerosis.
“Subsequent recruitment of granules to the plasma membrane (second phase) appears to depend on mitochondrial metabolites produced by anaplerosis (238).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [238] Hasan, 2008, Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase., J Biol Chem source
Not checked in the free run.
- Premisecitation
Mutation 14577 T>C, a missense substitution in the NADH dehydrogenase 6 gene, is another example of an mtDNA mutation associated with diabetes.
“Another example is mutation 14577 TϾC, a missense substitution in the NADH dehydrogenase 6 gene (245).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [245] Tawata, 2000, A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes., Diabetes source
Not checked in the free run.
- Premisecitation
Activation of UCP2 protects the β-cell from the deleterious effects of excess ROS by dissipating the proton gradient and decreasing ROS production in a controlled negative feedback manner.
“Thus, the activation of UCP2 protects the -cell from the deleterious effects of excess ROS (257) by dissipating the proton gradient and decreasing ROS production in a controlled negative feedback manner (Fig. 4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [257] Brand, 2005, The efficiency and plasticity of mitochondrial energy transduction., Biochem Soc Trans source
Not checked in the free run.
- Premisecitation
Higher levels of PGC-1α overexpression through actin promoter-driven expression in transgenic animals display a strikingly different phenotype.
“Higher levels of overexpression of PGC-1␣ achieved through actin promoter-driven expression in transgenic animals display a strikingly different phenotype (263,264).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [263] Miura, 2003, Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles., J Biol Chem source
Not checked in the free run.
- cites [264] Miura, 2006, Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP., Am J Pathol source
Not checked in the free run.
- Premisecitation
In a mixed background, UCP2 knockout improves glycemic control in ob/ob mice.
“In a mixed background, UCP2 knockout improves glycemic control in ob/ob mice (258), whereas in a pure C57BL6/J background, UCP2 knockout accelerates -cell failure and diabetes (259).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [258] Zhang, 2001, Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β-cell dysfunction, and type 2 diabetes., Cell source
Not checked in the free run.
- Interpretationcitation
High-level expression of PGC-1 may cause accumulation of lipids and/or incomplete oxidation products, leading to reduced insulin sensitivity, as observed in PGC-1α transgenic mice.
“Thus, high-level expression of PGC-1 may actually cause accumulation of lipids and/or incomplete oxidation products, leading to reduced insulin sensitivity, as observed in PGC-1␣ transgenic mice (267-269).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [267] Calvo, 2008, Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake., J Appl Physiol source
Not checked in the free run.
- cites [268] Lin, 2002, Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibers., Nature source
Not checked in the free run.
- cites [269] Sandri, 2006, PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription., Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
High-level expression of PGC-1α can induce increases in lipid oxidation genes and parallel increases in expression of genes promoting lipid uptake and synthesis.
“Moreover, high-level expression of PGC-1␣ can induce not only increases in lipid oxidation genes but also parallel increases in expression of genes promoting lipid uptake and synthesis (270).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [270] Choi, 2008, Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism., Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
When PGC-1α overexpression is restricted to skeletal muscle but overexpressed throughout development by the use of the creatine kinase gene promoter, very large increases in mitochondrial mass, OXPHOS, and fatty acid oxidation genes are observed.
“When PGC-1␣ overexpression is restricted to skeletal muscle but overexpressed throughout development by the use of the creatine kinase gene promoter, very large increases in mitochondrial mass, OXPHOS, and fatty acid oxidation genes are observed (267-269).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [267] Calvo, 2008, Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake., J Appl Physiol source
Not checked in the free run.
- cites [268] Lin, 2002, Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibers., Nature source
Not checked in the free run.
- cites [269] Sandri, 2006, PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription., Proc Natl Acad Sci USA source
Not checked in the free run.
- Interpretationreasoning
The net balance of these effects, and thus the net accumulation of pathogenic lipid species, is likely to be determined by the metabolic and hormonal milieu.
“The net balance of these effects, and thus the net accumulation of pathogenic lipid species, is likely to be determined by the metabolic and hormonal milieu.”
Quote in the paperSubstantial claim - Interpretationreasoning
Whole-body and inducible skeletal muscle- or cardiac-specific overexpression of PGC-1α can produce deleterious effects on muscle structure and function.
“Thus, whole-body and inducible skeletal muscle-or cardiac-specific overexpression of PGC-1␣ can produce deleterious effects on muscle structure and function.”
Quote in the paperSubstantial claim - Premisecitation
Mice with muscle-specific transgenic overexpression of PGC-1β displayed enhanced endurance and oxidative work.
“Mice displayed enhanced endurance and oxidative work (271).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [271] Arany, 2007, The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle., Cell Metab source
Not checked in the free run.
- Premisecitation
PGC-1α and PGC-1β coactivate different nuclear receptors.
“In addition, PGC-1␣ and PGC-1 coactivate different nuclear receptors (272).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [272] Kamei, 2003, PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity., Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
PGC-1β has distinct expression profiles in skeletal muscle, being expressed in parallel with myosin IIx rather than type I fibers.
“Although PGC-1-mediated gene expression and function appear to overlap considerably with that of PGC-1␣, PGC-1 has distinct expression profiles in skeletal muscle, being expressed in parallel with myosin IIx rather than type I fibers (271).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [271] Arany, 2007, The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle., Cell Metab source
Not checked in the free run.
- Premisecitation
Insulin resistance in these mice was paralleled by accumulation of triglycerides and long-chain acyl CoA.
“Insulin resistance was paralleled by accumulation of triglycerides and long-chain acyl CoA (270).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [270] Choi, 2008, Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism., Proc Natl Acad Sci USA source
Not checked in the free run.
- Interpretationreasoning
Inappropriate, nonphysiological regulation of PGC-1α expression may prevent appropriate modulation of oxidative metabolism with feeding/fasting, or exercise/recovery-the hallmarks of impaired metabolic flexibility observed in human insulin resistance.
“These results also suggest that inappropriate, nonphysiological regulation of PGC-1␣ expression may prevent appropriate modulation of oxidative metabolism with feeding/fasting, or exercise/recovery-the hallmarks of impaired metabolic flexibility observed in human insulin resistance.”
Quote in the paperSubstantial claim - Premisecitation
Polymorphisms at the ERRγ locus were found to be associated with increased glucose area under the curve in a genetic analysis of Old Order Amish subjects.
“Although the physiological effects of the related gene ERR␥ remain unclear, it interacts with PGC-1 to regulate expression of ERR␣ (278), and polymorphisms at this locus were found to be associated with increased glucose area under the curve in a genetic analysis of Old Order Amish subjects (279).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [279] Rampersaud, 2007, Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations., Diabetes source
Not checked in the free run.
- Premisecitation
Muscle is significantly more insulin sensitive in both whole-body and muscle-specific PGC-1α null mice.
“Interestingly, muscle is significantly more insulin sensitive in both whole-body and muscle-specific PGC-1␣ null mice.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [63] Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals., J Biol Chem source
Not checked in the free run.
- cites [64] Handschin, 2007, Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β-cell crosstalk., J Clin Invest source
Not checked in the free run.
- cites [68] Arany, 2005, Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle., Cell Metab source
Not checked in the free run.
- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
- Premisecitation
Many of these phenotypes are recapitulated in a muscle-specific PGC-1α knockout line.
“Many of these phenotypes are recapitulated in a muscle-specific PGC-1␣ knockout line (63, 64) (Table 2).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals., J Biol Chem source
Not checked in the free run.
- cites [64] Handschin, 2007, Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β-cell crosstalk., J Clin Invest source
Not checked in the free run.
- Interpretationcitation
Activation of AMP kinase in the setting of reduced ATP production may contribute to enhanced insulin sensitivity.
“Activation of AMP kinase in this setting of reduced ATP production may also contribute to enhanced insulin sensitivity (274).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [274] Pospisilik, 2007, Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes., Cell source
Not checked in the free run.
- Interpretationreasoning
Compensatory mechanisms elicited by complete lack of PGC-1α, which result in a leaner phenotype, may have a paradoxical insulin-sensitizing effect.
“It is possible that the compensatory mechanisms elicited by the complete lack of PGC-1␣, which result in a leaner phenotype, have a paradoxical insulin-sensitizing effect.”
Quote in the paperSubstantial claim - Premisecitation
Insulin sensitivity in PGC-1β-null mice is reported to be normal.
“Insulin sensitivity in these animals is reported to be normal.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [59] Sonoda, 2007, PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [62] Lai, 2008, Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart., Genes Dev source
Not checked in the free run.
- cites [65] Vianna, 2006, Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance., Cell Metab source
Not checked in the free run.
- cites [66] Lelliott, 2006, Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol source
Not checked in the free run.
- Premisecitation
PGC-1 family members interact with ERRs to transactivate transcription of oxidative genes and mitofusins.
“PGC-1 family members interact with the family of estrogen-related nuclear receptors, or ERRs, to transactivate transcription of oxidative genes (275) and mitofusins (276).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [275] Mootha, 2004, ERRα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [276] Soriano, 2006, Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-γ coactivator-1 α, estrogen-related receptor-α, and mitofusin 2., Diabetes source
Not checked in the free run.
- Interpretationcitation
The existence of compensation for PGC-1β deficiency by PGC-1α and vice versa is evidenced by the phenotype of double PGC-1α and PGC-1β muscle-specific knockout mice.
“The existence of compensation for PGC-1 deficiency by PGC-1␣ and vice versa is evidenced by the phenotype of double PGC-1␣ and PGC-1 muscle-specific knockout mice (62).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Lai, 2008, Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart., Genes Dev source
Not checked in the free run.
- Interpretationcitation
The paradoxical finding of increased insulin sensitivity in PGC-1α null mice may be explained by leanness and hyperactivity noted in one of the whole-body knockout lines.
“This apparently paradoxical finding-where decreased oxidative function is not paralleled by insulin resistance-may be explained by the leanness and hyperactivity noted in one of the whole-body knockout lines (68, 69).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [68] Arany, 2005, Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle., Cell Metab source
Not checked in the free run.
- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
- Interpretationcitation
Decreased metabolic efficiency may lead to enhanced whole-body fuel utilization and thus a leaner, more insulin-sensitive phenotype.
“For example, decreased metabolic efficiency (61), defined as decreased ATP produced per unit of oxidized fuel and/or oxygen, may lead to enhanced whole-body fuel utilization and thus a leaner, more insulin-sensitive phenotype.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Lehman, 2008, The transcriptional coactivator PGC-1α is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis, Am J Physiol Heart Circ Physiol source
Not checked in the free run.
- Interpretationcitation
In the muscle-specific knockout lines, reduction in food intake, body weight, and adiposity may contribute to insulin sensitivity.
“In the muscle-specific knockout lines, reduction in food intake, body weight, and adiposity (despite decreased physical activity) may also contribute to insulin sensitivity (63, 64).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [63] Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals., J Biol Chem source
Not checked in the free run.
- cites [64] Handschin, 2007, Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β-cell crosstalk., J Clin Invest source
Not checked in the free run.
- Interpretationreasoning
Reduced expression of PGC1 family genes and impaired oxidative function may play a more important, and potentially pathogenic, role in liver than in muscle.
“These data raise the possibility that reduced expression of PGC1 family genes and impaired oxidative function may play a more important, and potentially pathogenic role in liver than in muscle.”
Quote in the paperSubstantial claim - Interpretationreasoning
In each of these tissues, mitochondrial oxidative activity must be appropriate to fully oxidize nutrient loads, particularly fatty acids.
“In each of these tissues, mitochondrial oxidative activity must be appropriate to fully oxidize nutrient loads, particularly fatty acids.”
Quote in the paperSubstantial claim - Interpretationcitation
Resolution of oxidative stress can reverse insulin resistance.
“More importantly, resolution of oxidative stress can reverse insulin resistance.”
Quote in the paperSubstantial claim - Interpretationreasoning
Experimental induction of insulin resistance and/or components of the insulin-resistant/diabetes milieu may contribute to reductions in mitochondrial oxidative capacity, further fueling a vicious cycle of diabetes risk.
“Moreover, experimental induction of insulin resistance and/or components of the insulin-resistant/diabetes milieu may contribute to reductions in mitochondrial oxidative capacity, further fueling a vicious cycle of diabetes risk (Fig. 6).”
Quote in the paperSubstantial claim - Interpretationreasoning
Primary defects in mtDNA, even when produced experimentally by ablation of nuclear-encoded genes, do not produce overt metabolic phenotypes.
“Thus, these data indicate that primary defects in mtDNA, even when produced experimentally by ablation of nuclear-encoded genes, do not produce overt metabolic phenotypes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mitochondrial function in tissues involved in the pathogenesis of DM (liver, muscle, adipose tissue, and pancreatic β-cells) is critical for multiple aspects of cellular metabolism.
“Mitochondrial function in tissues involved in the pathogenesis of DM (liver, muscle, adipose tissue, and pancreatic -cells) is critical for multiple aspects of cellular metabolism.”
Quote in the paperSubstantial claim - Premisecitation
Whole-body PGC-1α transgenic expression driven by its own promoter increased mitochondrial DNA by 200-300% (Ward, 2009).
“1 200 -300%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- Interpretationreasoning
Balance is achieved when oxidative activity equals or exceeds fuel loads.
“Balance is achieved when oxidative activity equals or exceeds fuel loads.”
Quote in the paperSubstantial claim - Premisecitation
Knock-in mutant mice for POLG have accelerated aging potentially linked to impaired repair of mtDNA mutations.
“POLG-null mice die during embryogenesis with severe mtDNA depletion (283), whereas knock-in mutant mice have accelerated aging potentially linked to impaired repair of mtDNA mutations (284).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [284] Trifunovic, 2004, Premature ageing in mice expressing defective mitochondrial DNA polymerase., Nature source
Not checked in the free run.
- Interpretationreasoning
These observations are consistent with those in humans harboring mutations in mtDNA, where mitochondrial diabetes typically manifests as a gradual deterioration of pancreatic β-cell function.
“These observations are consistent with those in humans harboring mutations in mtDNA, where mitochondrial diabetes typically manifests as a gradual deterioration of pancreatic -cell function (see Section III.D).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Defects in resolution of oxidative stress may be another mechanism conferring increased risk for both mitochondrial dysfunction and insulin resistance.
“These data also suggest that defects in resolution of oxidative stress may be another mechanism conferring increased risk for both mitochondrial dysfunction and insulin resistance.”
Quote in the paperSubstantial claim - Interpretationreasoning
In experimental models in which mitochondrial oxidative capacity is severely restricted, insulin action is enhanced.
“Thus, in these experimental models in which mitochondrial oxidative capacity is severely restricted, insulin action is enhanced.”
Quote in the paperSubstantial claim - Premisecitation
POLG-null mice die during embryogenesis with severe mtDNA depletion.
“POLG-null mice die during embryogenesis with severe mtDNA depletion (283), whereas knock-in mutant mice have accelerated aging potentially linked to impaired repair of mtDNA mutations (284).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [283] Hance, 2005, Mitochondrial DNA polymerase γ is essential for mammalian embryogenesis., Hum Mol Genet source
Not checked in the free run.
- Interpretationreasoning
The sufficiency to fully oxidize fatty acids resides in the balance between net mitochondrial oxidative activity and fuel availability.
“The sufficiency to fully oxidize fatty acids resides in the balance between: 1) net mitochondrial oxidative activity, in turn determined by the need to generate energy to meet cellular demands, e.g., contraction and ion transport; and 2) fuel availability (determined by food intake, adiposity, and adipose storage capacity) (Fig. 5A).”
Quote in the paperSubstantial claim - Premisecitation
A high-fat, high-sucrose diet in the diabetes-prone C57BL6 mouse causes mitochondrial alterations in parallel with enhanced ROS production and impaired insulin sensitivity.
“For example, a high-fat, high-sucrose diet in the diabetes-prone C57BL6 mouse causes mitochondrial alterations in parallel with enhanced ROS production and impaired insulin sensitivity.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [286] Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [287] Anderson, 2009, Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart., J Am Coll Cardiol source
Not checked in the free run.
- cites [288] Bonnard, 2008, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice., J Clin Invest
Not checked in the free run.
- Interpretationreasoning
Chronic imbalance in energy metabolism due to overnutrition, obesity, and inactivity could directly contribute to increased cellular and mitochondrial ROS production.
“Secondly, chronic imbalance in energy metabolism due to overnutrition, obesity, and inactivity could directly contribute to increased cellular and mitochondrial ROS production.”
Quote in the paperSubstantial claim - Premisecitation
PGC-1α electroporation in muscle increased mitochondrial DNA by 113% (Benton, 2008).
“Mito DNA | 1 113%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [261] Benton, 2008, Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria., J Biol Chem source
Not checked in the free run.
- Interpretationreasoning
When sustained fuel excess exceeds energetic demands and/or oxidative capacity, and/or appropriate compensatory mechanisms are insufficient, a vicious cycle of insulin resistance and impaired insulin secretion can be initiated.
“However, when sustained fuel excess (e.g., resulting from overnutrition or impaired fat storage) exceeds energetic demands and/or oxidative capacity, and/or appropriate compensatory mechanisms are insufficient (e.g., due to inactivity or failure of mitochondria to adapt to higher cellular oxidative demands), a vicious cycle of insulin resistance and impaired insulin secretion can be initiated (Fig”
Quote in the paperSubstantial claim - Interpretationnone given
In isolation, reductions in mitochondrial activity mediated by genetic factors, epigenetic mechanisms, developmental exposures, and aging may not be sufficient to induce insulin resistance.
“In isolation, reductions in mitochondrial activity mediated by genetic factors (family history, ethnicity), epigenetic mechanisms, developmental exposures, and aging may not be sufficient to induce insulin resistance.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Individuals with high oxidative capacity or adaptive responses would have high tolerance to large fuel loads.
“Thus, individuals with a high oxidative capacity or adaptive responses would have high tolerance to large fuel loads.”
Quote in the paperSubstantial claim - Interpretationreasoning
Interindividual variation in oxidative capacity and/or activity, fuel load, or ability to modulate mitochondrial activity, increase mitochondrial capacity, or resolve oxidative stress could determine the set point of metabolic balance.
“In this context, interindividual variation in oxidative capacity and/or activity, fuel load, or ability to modulate mitochondrial activity (acute response), increase mitochondrial capacity (chronic response), or resolve oxidative stress could determine the set point of metabolic balance.”
Quote in the paperNot a substantial claim - Premisecitation
PGC-1α and PGC-1β muscle-specific double knockout reduced mitochondrial DNA by 60% in heart (Lai, 2008).
“Lai, 2008 (62) PGC-1␣ and PGC-1 2 60%, heart | muscle-specific KO”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Lai, 2008, Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart., Genes Dev source
Not checked in the free run.
- May combine two claims. 142
- Classified as probably not a substantial claim. 18
- The quote only partly states this claim. 1
May combine two claims.
FindingcitationRates of mitochondrial OXPHOS in offspring of type 2 diabetic subjects, assessed by 31P spectroscopy, are reduced by 30% in the fasting state, and TCA cycle flux is reduced by 30%.
“For example, rates of mitochondrial OXPHOS in offspring of type 2 diabetic subjects, as assessed by 31 P spectroscopy, are reduced by 30% in the fasting state (117), and TCA cycle flux, modeled using rates of 4-13 C-glutamate enrichment during infusion of 13 C-acetate, is reduced by 30% (118).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [117] Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes., N Engl J Med source
Not checked in the free run.
- cites [118] Befroy, 2007, Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients., Diabetes source
Not checked in the free run.
May combine two claims.
FindingcitationInsulin-stimulated ATP synthesis is reduced by more than 90% in nonobese first-degree relatives of type 2 diabetics, more than would be expected from the 30% decrease in mitochondrial density and oxidative function observed in the same population.
“Similarly, insulin-stimulated ATP synthesis is reduced by more than 90% in nonobese first-degree relatives of type 2 diabetics (120), more than would be expected from the 30% decrease in mitochondrial density and oxidative function observed in the same population.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Petersen, 2005, Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents, PLoS Med source
Not checked in the free run.
May combine two claims.
FindingcitationThe enzymatic activity of OXPHOS complex I is reduced by about 40% in skeletal muscle biopsy samples from individuals with type 2 DM and by 20% in obese individuals.
“Ritov et al. (114) demonstrated that the enzymatic activity of OXPHOS complex I, as assessed by the activity of rotenone-sensitive NADH:O 2 oxidoreductase, was reduced by about 40% in skeletal muscle biopsy samples from individuals with type 2 DM and by 20% in obese individuals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [114] Ritov, 2005, Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes., Diabetes source
Not checked in the free run.
May combine two claims.
FindingcitationMaximal ADP-stimulated respiration (state 3, malate and pyruvate as substrates) is decreased in mitochondria isolated from obese subjects with DM compared with obesity alone, and these differences persist after normalization to citrate synthase activity.
“Mogensen et al. (119) observed decreases in maximal ADP-stimulated respiration (state 3, malate and pyruvate as substrates) in mitochondria isolated from obese subjects with DM as compared with obesity alone; these differences persisted even after normalization to citrate synthase activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes., Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn cultured C2C12 mouse myoblasts, the mitochondrial reticulum is dynamic, with scission, branching, and fusion events occurring at 30-second intervals.
“The comparison between successive frames reveals scission events (arrowheads), branching events (V), and fusion events (brackets) occurring at 30-sec intervals.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth obesity and related inactivity are likely to contribute to the pathogenesis of diabetes.
“Both obesity and related inactivity are likely to contribute to the pathogenesis of diabetes because the incidence of diabetes can be reduced by modest weight loss and exercise (7)(8)(9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (7)(8)(9)
Not checked in the free run.
May combine two claims.
PremisecitationInsulin resistance is not predictive of diabetes in individuals without a family history of diabetes, indicating that additional unidentified factors are necessary for disease progression.
“However, insulin resistance is not predictive of diabetes in individuals without a family history of diabetes, indicating that additional unidentified factors are necessary for disease progression (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Goldfine, 2003, Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease., Proc Natl Acad Sci USA source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S4 (based).
Interpretationnone givenGenetically determined and/or inactivity-mediated alterations in mitochondrial oxidative activity may directly impact adaptive responses to overnutrition, causing an imbalance between oxidative activity and nutrient load.
“However, we hypothesize that genetically determined and/or inactivity-mediated alterations in mitochondrial oxidative activity may directly impact adaptive responses to overnutrition, causing an imbalance between oxidative activity and nutrient load.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe association between impaired mitochondrial function and type 2 diabetes is strong, but a causal pathogenic relationship remains uncertain.
“We conclude that, whereas the association between impaired mitochondrial function and DM is strong, a causal pathogenic relationship remains uncertain.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationIn addition to decreased mitochondrial density, there is an intrinsic defect(s) in TCA, OXPHOS, membrane potential, or adenine nucleotide transporters in mitochondria of individuals with established diabetes.
“Thus, these data suggest that in addition to decreased mitochondrial density, there is an additional intrinsic defect(s) in TCA, OXPHOS, membrane potential, or adenine nucleotide transporters in mitochondria of individuals with established diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Asian Indian subjects, expression of OXPHOS and TCA cycle genes, mtDNA content, and ATP production rates were higher in both nondiabetic and diabetic individuals compared with Northern European controls, despite lower overall insulin sensitivity.
“In these individuals, expression of OXPHOS and TCA cycle genes, mtDNA content, and ATP production rates were actually higher in both nondiabetic and diabetic individuals compared with Northern European controls, despite lower overall insulin sensitivity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] Nair, 2008, Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance., Diabetes source
Not checked in the free run.
May combine two claims.
InterpretationcitationHuman insulin resistance is accompanied by impaired in vivo mitochondrial oxidative function, linked at least in part to reduced mitochondrial density.
“Multiple studies suggest that human insulin resistance is indeed accompanied by impaired in vivo mitochondrial oxidative function-in turn linked, at least in part, to reduced mitochondrial density.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn studies of muscle oxidative capacity, differences did not remain after normalization for mitochondrial mass by citrate synthase activity or mtDNA content, suggesting reduced mitochondrial mass might be a major contributor.
“In each of these studies, differences in oxidative capacity did not remain after normalization for mitochondrial mass by citrate synthase activity or mtDNA content, respectively, suggesting that reduced mitochondrial mass might be a major contributor.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe magnitude of these changes is similar to the 38% lower muscle mitochondrial density in this same population, suggesting decreased mitochondrial density might be an important factor in reduced oxidative capacity in individuals with a family history of diabetes.
“The magnitude of these changes is strikingly similar to the 38% lower muscle mitochondrial density, assessed by electron microscopy, in this same population-again suggesting that decreased mitochondrial density might be an important factor in reduced oxidative capacity in individuals with a family history of diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationAdditional mechanisms potentially linking impaired mitochondrial oxidative function to insulin resistance include reduced ATP synthesis for energy-requiring functions, abnormalities in calcium homeostasis, and reduced ATP production during exercise.
“Additional mechanisms potentially linking impaired mitochondrial oxidative function to insulin resistance include: 1) reduced ATP synthesis for energyrequiring functions such as insulin-stimulated glucose uptake; 2) abnormalities in calcium homeostasis (necessary for exercise-induced glucose uptake) (103-105); and 3) reduced ATP production during exercise (106), potentially contributing to reduced”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [103] Lanner, 2008, Ca(2+) and insulin-mediated glucose uptake., Curr Opin Pharmacol source
Not checked in the free run.
- cites [104] Lebeche, 2008, Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy., Nat Clin Pract Cardiovasc Med source
Not checked in the free run.
- cites [105] Park, 2009, Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle, Am J Physiol Cell Physiol source
Not checked in the free run.
- cites [106] Kacerovsky-Bielesz, 2009, Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes., Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationPrimary myotubes isolated from obese humans with type 2 DM display reduced basal lipid oxidation and insulin-stimulated glucose oxidation with no differences in OXPHOS gene expression.
“For example, primary myotubes isolated from obese humans with type 2 DM display reduced basal lipid oxidation and insulinstimulated glucose oxidation with no differences in OXPHOS gene expression (126).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [126] Frederiksen, 2008, Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes., Diabetologia source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S2 (checkable).
InterpretationreasoningLevels of OXPHOS gene expression and function must be considered relative to the oxidative fuel load in an individual.
“These results also raise the question of whether levels of OXPHOS gene expression and function must be considered relative to the oxidative fuel load in an individual.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMitochondrial functional capacity is likely to directly affect muscle metabolic function and, because of its large contribution to total body mass, to have a significant impact on whole-body metabolism.
“Thus, mitochondrial functional capacity is likely to directly affect muscle metabolic function and, because of its large contribution to total body mass, to have a significant impact on whole-body metabolism.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationImpaired metabolic flexibility correlates with intramyocellular accumulation of lipids, and 24-h RQ can predict subsequent weight gain.
“Impaired flexibility also correlates with intramyocellular accumulation of lipids (107), and 24-h RQ can predict subsequent weight gain (110, 113).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [107] Simoneau, 1995, Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women., FASEB J source
Not checked in the free run.
- cites [110] Bruce, 2003, Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status., J Clin Endocrinol Metab source
Not checked in the free run.
- cites [113] Zurlo, 1990, Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ, Am J Physiol
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningDifferences in OXPHOS gene expression between populations may reflect population-specific differences in obesity, physical fitness, or ethnicity.
“These differences may reflect population-specific differences in obesity, physical fitness, or ethnicity.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationIncreased tissue lipid load, as with obesity and/or sustained inactivity, may lead to accumulation of fatty acyl CoA, diacylglycerols, ceramides, products of incomplete oxidation, and ROS, all of which have been linked experimentally to reduced insulin signaling and action.
“Increased tissue lipid load, as with obesity, and/or sustained inactivity, may lead to the accumulation of fatty acyl coenzyme A (CoA), diacylglycerols, ceramides, products of incomplete oxidation, and ROS, all of which have been linked experimentally to reduced insulin signaling and action (96 -102).”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [96] Dresner, 1999, Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity., J Clin Invest source
Not checked in the free run.
- cites [97] Savage, 2007, Disordered lipid metabolism and the pathogenesis of insulin resistance., Physiol Rev source
Not checked in the free run.
- cites [98] Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance., Cell Metab source
Not checked in the free run.
- cites [99] Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance., Cell Metab source
Not checked in the free run.
- cites [100] Yu, 2002, Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle., J Biol Chem source
Not checked in the free run.
- cites [101] Chibalin, 2008, Downregulation of diacylglycerol kinase δ contributes to hyperglycemia-induced insulin resistance., Cell source
Not checked in the free run.
- cites [102] Houstis, 2006, Reactive oxygen species have a causal role in multiple forms of insulin resistance., Nature source
Not checked in the free run.
May combine two claims.
PremisecitationLipid excess has been linked experimentally to induction of insulin resistance and alterations in insulin signal transduction.
“Moreover, lipid excess has been linked experimentally to induction of insulin resistance (96) and alterations in insulin signal transduction (97-99).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [96] Dresner, 1999, Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity., J Clin Invest source
Not checked in the free run.
- cites [97] Savage, 2007, Disordered lipid metabolism and the pathogenesis of insulin resistance., Physiol Rev source
Not checked in the free run.
- cites [98] Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance., Cell Metab source
Not checked in the free run.
- cites [99] Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance., Cell Metab source
Not checked in the free run.
May combine two claims.
InterpretationreasoningHigh OXPHOS expression in the Asian Indian population may still be inadequate for appropriate and complete oxidation of a chronic high load of circulating lipids, whereas lower OXPHOS levels may be sufficient under conditions of a low circulating lipid load.
“For example, high OXPHOS expression in the population mentioned above may still be inadequate for appropriate and complete oxidation of a chronic high load of circulating lipids, whereas lower OXPHOS levels may be sufficient under conditions of a low circulating lipid load (see Fig. 5).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIntramyocellular lipid excess strongly correlates with the severity of insulin resistance, even after correction for the degree of obesity, and has been observed in muscles of multiple fiber types.
“Although it remains unclear whether any of these defects play a causal role in insulin resistance, intramyocellular lipid excess strongly correlates with the severity of insulin resistance, even after correction for the degree of obesity (94), and has been observed in muscles of multiple fiber types (95).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [94] Jacob, 1999, Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects., Diabetes source
Not checked in the free run.
- cites [95] Malenfant, 2001, Fat content in individual muscle fibers of lean and obese subjects., Int J Obes Relat Metab Disord source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGenetic polymorphisms may also influence age-dependent reductions in expression.
“Genetic polymorphisms may also influence age-dependent reductions in expression (137).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins., J Clin Invest source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α has been recognized as an important coactivator in skeletal muscle, contributing to fiber type determination, glucose uptake, and oxidative capacity.
“PGC-1␣ has been recognized as an important coactivator in skeletal muscle, contributing to fiber type determination, glucose uptake, and oxidative capacity (see Section IV.A).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Section IV.A
Not checked in the free run.
May combine two claims.
PremisecitationOXPHOS expression can be increased with exercise training, a potent insulin sensitizer.
“Conversely, OXPHOS expression can be increased with exercise training (133, 135), a potent insulin sensitizer.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [133] Parikh, 2008, Molecular correlates for maximal oxygen uptake and type 1 fibers, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [135] Wright, 2007, Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationExpression of multiple OXPHOS genes is markedly reduced in mice made insulin deficient by treatment with the β-cell toxin streptozotocin, and can be normalized by insulin.
“Expression of multiple OXPHOS genes is also markedly reduced in mice made insulin deficient by treatment with the -cell toxin streptozotocin, and can be normalized by insulin (141).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Yechoor, 2002, Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice., Proc Natl Acad Sci USA source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningPatterns of differential OXPHOS expression may be more readily detectable in disease states, yet not necessarily mirror other aspects of mitochondrial oxidative capacity.
“Additionally, because OXPHOS gene expression is coordinately regulated, patterns of differential OXPHOS expression may be more readily detectable in disease states, yet not necessarily mirror other aspects of mitochondrial oxidative capacity.”
Quote in the paperNot a substantial claim- Rests on an assumption: OXPHOS gene expression is coordinately regulated.
May combine two claims.
PremisecitationAlterations in muscle PGC-1α and -β mRNA expression are observed in humans with insulin resistance-being reduced by nearly 50% in muscle from individuals with diabetes and in some populations of normoglycemic insulin-resistant humans.
“Moreover, alterations in muscle PGC-1␣ and - mRNA expression are observed in humans with insulin resistance-being reduced by nearly 50% in muscle from individuals with diabetes (122, 145) and in some populations of normoglycemic insulin-resistant humans (121, 124, 137).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [122] Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [145] Southgate, 2005, PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle., FASEB J source
Not checked in the free run.
- cites [121] Mootha, 2003, PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes., Nat Genet source
Not checked in the free run.
- cites [124] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents., J Clin Invest source
Not checked in the free run.
- cites [137] Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins., J Clin Invest source
Not checked in the free run.
May combine two claims.
PremisecitationExperimental insulin therapy does not modulate mitochondrial respiration, so mechanisms linking insulin action with OXPHOS gene expression remain unclear.
“Moreover, experimental insulin therapy does not modulate mitochondrial respiration (144), so mechanisms linking insulin action with OXPHOS gene expression remain unclear.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [144] Rabøl, 2009, Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes., J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1 activity can also be modulated at the level of translation and by posttranscriptional changes, including inhibitory GCN5-mediated acetylation and stimulatory sirtuin 1 mediated deacetylation.
“PGC-1 activity can also be modulated at the level of translation and by posttranscriptional changes, including inhibitory GCN5-mediated acetylation (147) and stimulatory sirtuin 1 mediated deacetylation (148).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [147] Lerin, 2006, GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α., Cell Metab source
Not checked in the free run.
- cites [148] Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α., Cell source
Not checked in the free run.
May combine two claims.
PremisecitationShort-term experimental induction of acute hyperglycemia in humans does not fully mirror this pattern of gene expression, suggesting that the response to insulin deficiency is not completely due to resultant hyperglycemia.
“Short-term experimental induction of acute hyperglycemia in humans does not fully mirror this pattern of gene expression (143), suggesting that the response to insulin deficiency is not completely due to resultant hyperglycemia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Meugnier, 2007, Acute hyperglycemia induces a global downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects., Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThese multiple modes of PGC-1α regulation are likely to have evolved from the need to adapt mitochondrial energy metabolism in response to increasingly diverse inputs.
“These multiple modes of PGC-1␣ regulation are likely to have evolved from the need to adapt mitochondrial energy metabolism in response to increasingly diverse inputs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSome studies demonstrate that high-fat feeding is associated with increased numbers of mitochondrial protein and DNA content, potentially mediated by chronic fatty acid activation of PPAR nuclear receptors.
“However, these responses are not observed in all studies of high-fat feeding; in fact, some studies demonstrate that high-fat feeding is associated with increased numbers of mitochondrial protein and DNA content, potentially mediated by chronic fatty acid activation of PPAR nuclear receptors (130 -132).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [130] Garcia-Roves, 2007, Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [131] Hancock, 2008, High-fat diets cause insulin resistance despite an increase in muscle mitochondria., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [132] Sreekumar, 2002, Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α expression may also be reduced as a consequence of promoter methylation or caused by insulin itself, obesity, and sustained lipid exposure.
“In turn, PGC-1␣ expression may also be reduced as a consequence of promoter methylation (146) or caused by insulin itself (145), obesity (126), and sustained lipid exposure (126).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [146] Barrès, 2009, Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density., Cell Metab source
Not checked in the free run.
- cites [145] Southgate, 2005, PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle., FASEB J source
Not checked in the free run.
- cites [126] Frederiksen, 2008, Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes., Diabetologia source
Not checked in the free run.
May combine two claims.
InterpretationreasoningGenetic background, age at dietary intervention, specific dietary lipid composition, and duration of diet may be important variables to consider when analyzing the interaction between OXPHOS gene expression and diet.
“Together, these seemingly disparate data suggest that genetic background (127), age at dietary intervention, specific dietary lipid composition, and duration of diet may be important variables to consider when analyzing the interaction between OXPHOS gene expression and diet.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationUCP1 hinders the establishment of, or dissipates, a proton gradient of sufficient magnitude to sustain the synthetic activity of the mitochondrial ATPase, thus driving continuous accelerated electron transport.
“UCP1 hinders the establishment of, or dissipates, a proton gradient of sufficient magnitude to sustain the synthetic activity of the mitochondrial ATPase (150, 153-155), thus driving continuous accelerated electron transport.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [150] Cannon, 1985, The biochemistry of an inefficient tissue: brown adipose tissue., Essays Biochem
Not checked in the free run.
- cites [153] Bouillaud, 1985, Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [154] Jacobsson, 1985, Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression., J Biol Chem source
Not checked in the free run.
- cites [155] Ricquier, 1997, The mitochondrial uncoupling protein: structural and genetic studies., Prog Nucleic Acid Res Mol Biol source
Not checked in the free run.
May combine two claims.
PremisecitationAmong the mitochondrial functions that may be relevant for white adipose tissue function are the anaplerotic generation of metabolic intermediates for fatty acid synthesis and esterification, the maintenance of a robust pathway for the folding and secretion of high abundance circulating proteins such as adiponectin, and interactions between mitochondrial function and components of the insulin-sign
“Among the mitochondrial functions that may be relevant for white adipose tissue function are the anaplerotic generation of metabolic intermediates for fatty acid synthesis and esterification (159), the maintenance of a robust pathway for the folding and secretion of high abundance circulating proteins such as adiponectin (160), and interactions between mitochondrial function and components of the”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [159] Owen, 2002, The key role of anaplerosis and cataplerosis for citric acid cycle function., J Biol Chem source
Not checked in the free run.
- cites [160] Koh, 2007, Essential role of mitochondrial function in adiponectin synthesis in adipocytes., Diabetes source
Not checked in the free run.
- cites [161] Shi, 2008, Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells., J Biol Chem source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAlterations in relative utilization of substrates, an imbalance between fuel load and cellular energy requirements, and/or differential thresholds for generation of or resolution of oxidative stress in this setting may contribute to differential susceptibility to insulin resistance in muscle.
“Rather, alterations in relative utilization of substrates, an imbalance between fuel load and cellular energy requirements, and/or differential thresholds for generation of or resolution of oxidative stress in this setting may contribute to differential susceptibility to insulin resistance in muscle.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationRecent work has led to reconsideration of the notion that the role of brown adipose tissue in human metabolism is minor, noting that humans possess adipose tissue depots that are cold-sensitive and hypermetabolic, as assessed by their very high uptake of labeled glucose.
“However, recent work has led to reconsideration of this notion, noting that humans possess adipose tissue depots that are cold-sensitive and hypermetabolic, as assessed by their very high uptake of labeled glucose (152,163).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [152] Weber, 2004, Brown adipose tissue and nuclear medicine imaging., J Nucl Med
Not checked in the free run.
- cites [163] Nedergaard, 2007, Unexpected evidence for active brown adipose tissue in adult humans, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial density increases dramatically, and mitochondrial remodeling occurs during white adipocyte differentiation, suggesting that mitochondrial functions are required to support the multiple biological roles of mature white adipocytes.
“However, mitochondrial density increases dramatically, and mitochondrial remodeling occurs during white adipocyte differentiation (156 -158), suggesting that mitochondrial functions are required to support the multiple biological roles of mature white adipocytes.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [156] Luo, 2008, Alteration of mitochondrial oxidative capacity during porcine preadipocyte differentiation and in response to leptin., Mol Cell Biochem source
Not checked in the free run.
- cites [157] Kim, 2004, Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts., Exp Mol Med source
Not checked in the free run.
- cites [158] Wilson-Fritch, 2003, Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone., Mol Cell Biol source
Not checked in the free run.
May combine two claims.
PremisecitationThe role of adipose tissue mitochondria is most apparent in brown adipose tissue, where flux through the ETC generates heat in the process of thermogenesis, a potentially important mechanism regulating systemic metabolism even in adult humans.
“The role of adipose tissue mitochondria is most apparent in brown adipose tissue, where flux through the ETC generates heat in the process of thermogenesis, a potentially important mechanism regulating systemic metabolism even in adult humans (149 -152).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [149] Astrup, 1986, Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation., Acta Endocrinol Suppl (Copenh)
Not checked in the free run.
- cites [150] Cannon, 1985, The biochemistry of an inefficient tissue: brown adipose tissue., Essays Biochem
Not checked in the free run.
- cites [151] Cypess, 2009, Identification and importance of brown adipose tissue in adult humans., N Engl J Med source
Not checked in the free run.
- cites [152] Weber, 2004, Brown adipose tissue and nuclear medicine imaging., J Nucl Med
Not checked in the free run.
May combine two claims.
PremisecitationHigher mitochondrial density and even UCP1 can be induced in response to pharmacological or genetic alterations of white adipocytes, suggesting that white adipose tissue could potentially be induced to acquire more oxidative metabolic phenotypes, promoting increased fuel consumption and thus energy expenditure.
“Higher mitochondrial density and even UCP1 can be induced in response to pharmacological or genetic alterations of white adipocytes (170 -177), suggesting that white adipose tissue could potentially be induced to acquire more oxidative metabolic phenotypes, promoting increased fuel consumption and thus energy expenditure.”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [170] Bogacka, 2005, Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo., Diabetes source
Not checked in the free run.
- cites [171] Himms-Hagen, 2000, Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes, Am J Physiol Cell Physiol source
Not checked in the free run.
- cites [172] Loncar, 1991, Convertible adipose tissue in mice., Cell Tissue Res source
Not checked in the free run.
- cites [173] Orci, 2004, Rapid transformation of white adipocytes into fat-oxidizing machines., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [174] Ström, 2008, Attainment of brown adipocyte features in white adipocytes of hormone-sensitive lipase null mice, PLoS ONE source
Not checked in the free run.
- cites [175] Tiraby, 2003, Acquirement of brown fat cell features by human white adipocytes., J Biol Chem source
Not checked in the free run.
- cites [176] Toh, 2008, Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice, PLoS ONE source
Not checked in the free run.
- cites [177] Wilson-Fritch, 2004, Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone., J Clin Invest source
Not checked in the free run.
May combine two claims.
PremisecitationThe large capacity of brown adipose tissue mitochondria to oxidize fatty acids results in a measurable impact on whole-body metabolism; increased brown adipose tissue abundance correlates negatively with fuel storage and weight gain in rodents, and vice versa.
“The large capacity of brown adipose tissue mitochondria to oxidize fatty acids results in a measurable impact on whole-body metabolism; increased brown adipose tissue abundance correlates negatively with fuel storage and weight gain in rodents, and vice versa (162).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [162] Marette, 1991, Mechanism linking insulin resistance to defective thermogenesis in brown adipose tissue of obese diabetic SHR/N-cp rats., Int J Obes
Not checked in the free run.
May combine two claims.
InterpretationreasoningImpaired mitochondrial capacity in brown adipose tissue might be functionally linked to impaired thermogenesis and energy expenditure, and thus increased susceptibility to obesity-linked insulin resistance.
“Thus, impaired mitochondrial capacity in brown adipose tissue might be functionally linked to impaired thermogenesis and energy expenditure, and thus increased susceptibility to obesity-linked insulin resistance.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationWhite adipocytes display a high degree of plasticity, and regional differences in metabolic activity can be linked to varying mitochondria densities.
“White adipocytes display a high degree of plasticity (168), and regional differences in metabolic activity can be linked to varying mitochondria densities (169).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [168] Cinti, 2002, Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ., J Endocrinol Invest source
Not checked in the free run.
- cites [169] Deveaud, 2004, Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes., Mol Cell Biochem source
Not checked in the free run.
May combine two claims.
PremisecitationWhite adipocyte mitochondrial content is decreased in both rodent and human obesity and correlates with insulin resistance that accompanies obesity.
“White adipocyte mitochondrial content is decreased in both rodent and human obesity (177, 188 -191) and correlates with insulin resistance that accompanies obesity.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [177] Wilson-Fritch, 2004, Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone., J Clin Invest source
Not checked in the free run.
- cites [188] Choo, 2006, Mitochondria are impaired in the adipocytes of type 2 diabetic mice., Diabetologia source
Not checked in the free run.
- cites [189] Okamoto, 2007, Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice., Exp Mol Pathol source
Not checked in the free run.
- cites [190] Rong, 2007, Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone., Diabetes source
Not checked in the free run.
- cites [191] Sutherland, 2008, Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationIn humans, white adipocyte mtDNA copy number is inversely correlated with age and BMI and directly correlated with basal and insulin-induced lipogenesis.
“In humans, white adipocyte mtDNA copy number is inversely correlated with age and BMI and directly correlated with basal and insulin-induced lipogenesis (192).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [192] Kaaman, 2007, Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue., Diabetologia source
Not checked in the free run.
May combine two claims.
PremisecitationBoth genetic and diet-induced obesity result in decreased mitochondrial density and OXPHOS activity in adipose tissue, potentially contributing to adipose tissue dysfunction and exacerbation of insulin resistance.
“Conversely, both genetic and dietinduced obesity result in decreased mitochondrial density and OXPHOS activity in adipose tissue (127, 177, 189 -191), potentially contributing to adipose tissue dysfunction and exacerbation of insulin resistance.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [127] Crunkhorn, 2007, Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation., J Biol Chem source
Not checked in the free run.
- cites [177] Wilson-Fritch, 2004, Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone., J Clin Invest source
Not checked in the free run.
- cites [189] Okamoto, 2007, Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice., Exp Mol Pathol source
Not checked in the free run.
- cites [190] Rong, 2007, Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone., Diabetes source
Not checked in the free run.
- cites [191] Sutherland, 2008, Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationMice deficient in Fsp27, a lipid droplet protein that promotes lipid storage in white and brown adipocytes, have increased whole-body energy expenditure, resistance to diet-induced obesity, and enhanced insulin sensitivity.
“For example, Toh et al. (176) and Nishino,et al. (205) find that mice deficient in Fsp27, a lipid droplet protein that promotes lipid storage in white and brown adipocytes, have increased whole-body energy expenditure, resistance to diet-induced obesity, and enhanced insulin sensitivity.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [176] Toh, 2008, Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice, PLoS ONE source
Not checked in the free run.
- cites [205] Nishino, 2008, FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets., J Clin Invest
Not checked in the free run.
May combine two claims.
PremisecitationProtein expression of multiple OXPHOS components and Tfam (expressed per milligram of protein) and citrate synthase activity are also lower in liver (e.g., 7% that of cardiac muscle).
“Protein expression of multiple OXPHOS components and Tfam (expressed per milligram of protein) and citrate synthase activity are also lower in liver (e.g., 7% that of cardiac muscle) (211).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [211] Benard, 2006, Physiological diversity of mitochondrial oxidative phosphorylation, Am J Physiol Cell Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationElectron microscopy demonstrates that mitochondrial area is 44% lower in liver than in heart with smaller size, fewer cristae, and lower matrix density.
“Electron microscopy demonstrates that mitochondrial area is 44% lower in liver than in heart (210) with smaller size, fewer cristae, and lower matrix density.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [210] Veltri, 1990, Distinct genomic copy number in mitochondria of different mammalian organs., J Cell Physiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenCurrent reports support the hypothesis that brown adipocytes and myocytes share a common cellular lineage, potentially explaining their similarity with regard to containing mitochondria specialized in fuel oxidation.
“Current reports support the hypothesis that brown adipocytes and myocytes share a common cellular lineage, potentially explaining their similarity with regard to containing mitochondria specialized in fuel oxidation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDespite lower OXPHOS capacity, state 3 respiration and respiratory control ratio are equivalent in liver and muscle, indicating differences in relative substrate concentrations and lower 'excess capacity' in liver.
“Despite lower OXPHOS capacity, state 3 respiration and respiratory control ratio are equivalent in liver and muscle, indicating differences in relative substrate concentrations and lower”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [211] Benard, 2006, Physiological diversity of mitochondrial oxidative phosphorylation, Am J Physiol Cell Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationIsolated hepatic mitochondria have relative reductions in OXPHOS proteins, respiratory chain cytochromes, and maximal activity of complexes III and IV.
“Functionally, isolated hepatic mitochondria have relative reductions in OXPHOS proteins, respiratory chain cytochromes, and maximal activity of complexes III and IV (211).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [211] Benard, 2006, Physiological diversity of mitochondrial oxidative phosphorylation, Am J Physiol Cell Physiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTranscriptional coactivators PGC-1α and -1β play a critical role in the expansion of the mitochondrial reticulum and in the induction of UCP1 and the brown adipose tissue thermogenic program during the perinatal period.
“In addition, the transcriptional coactivators PGC-1␣ and -1 (56) play a critical role in the expansion of the mitochondrial reticulum and in the induction of UCP1 and the brown adipose tissue thermogenic program during the perinatal period (59).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [56] Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1., Cell source
Not checked in the free run.
- cites [59] Sonoda, 2007, PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
PremisecitationLIRKO mice are also dyslipidemic and susceptible to atherosclerosis.
“Interestingly, these mice are also dyslipidemic and susceptible to atherosclerosis (209).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [209] Biddinger, 2008, Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis., Cell Metab source
Not checked in the free run.
May combine two claims.
InterpretationcitationMechanisms that induce and maintain active mitochondria in adipocytes can bypass defects in insulin signaling, and indeed, insulin signaling may repress mitochondrial gene expression and/or function.
“Thus, mechanisms that induce and maintain active mitochondria in adipocytes can bypass defects in insulin signaling, and indeed, insulin signaling may repress mitochondrial gene expression and/or function.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationMechanisms whereby obesity results in a reduction in adipose mitochondrial density are not known but could be mediated by decreased expression of PGC-1α, as observed in obese humans.
“The mechanisms whereby obesity results in a reduction in adipose mitochondrial density are not known but could be mediated by decreased expression of PGC-1␣, as observed in obese humans (206).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [206] Semple, 2004, Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects., Int J Obes Relat Metab Disord source
Not checked in the free run.
May combine two claims.
PremisecitationLiver-specific insulin receptor knockout (LIRKO) mice develop insulin resistance, glucose intolerance, impaired insulin suppression of hepatic glucose production, and altered patterns of hepatic gene expression.
“For example, liver-specific insulin receptor knockout (LIRKO) mice develop insulin resistance, glucose intolerance, impaired insulin suppression of hepatic glucose production, and altered patterns of hepatic gene expression (208).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [208] Michael, 2000, Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction., Mol Cell source
Not checked in the free run.
May combine two claims.
InterpretationreasoningReduced mtDNA content could reduce adipocyte capacity for lipid storage, promoting ectopic lipid accumulation in peripheral tissues such as muscle and liver.
“Thus, reduced mtDNA content could reduce adipocyte capacity for lipid storage, promoting ectopic lipid accumulation in peripheral tissues such as muscle and liver.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMitochondrial levels in white adipocytes are also increased in response to adrenergic stimulation, β-3 agonists, and CB1 blockade in mice, again in parallel with enhanced insulin sensitivity.
“Mitochondrial levels in white adipocytes are also increased in response to adrenergic stimulation, -3 agonists, and CB1 blockade in mice (195,199,200), again in parallel with enhanced insulin sensitivity.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [195] Bogacka, 2005, Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro., J Clin Endocrinol Metab source
Not checked in the free run.
- cites [199] Granneman, 2005, Metabolic and cellular plasticity in white adipose tissue I: effects of β3-adrenergic receptor activation, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [200] Tedesco, 2008, Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes., Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationReduced OXPHOS activity in NASH is accompanied by increased tissue long-chain acylcarnitines and reduced short-chain acylcarnitines, despite normal CPT1 activity and increased expression of β-oxidation genes.
“Although these data cannot address whether such changes are indeed pathogenic, it is interesting that reduced OXPHOS activity in this setting is accompanied by increased tissue long-chain acylcarnitines and reduced short-chain acylcarnitines, despite normal CPT1 activity and increased expression of -oxidation genes (230, 236).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [230] Misu, 2007, Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes., Diabetologia source
Not checked in the free run.
- cites [236] Kohjima, 2007, Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease., Int J Mol Med
Not checked in the free run.
May combine two claims.
PremisecitationEffects of fatty acids in liver cells can be prevented by inhibition of CPT1, indicating a critical role for mitochondrial oxidation in inducing lipid-mediated insulin resistance, perhaps via products of incomplete oxidation and/or generation of ROS.
“Although these effects could be mediated by accumulation of fatty acyl CoA, diacylglycerols, and ceramides (as in muscle; Section III.A), it is intriguing that effects of fatty acids in liver cells can be prevented by inhibition of CPT1, indicating a critical role for mitochondrial oxidation in inducing lipid-mediated insulin resistance, perhaps via products of incomplete oxidation and/or”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [220] Nakamura, 2009, Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria., J Biol Chem source
Not checked in the free run.
May combine two claims.
InterpretationcitationByproducts of incomplete fatty acid oxidation could act in concert with adipose tissue-derived inflammatory signals (e.g., TNFα), and altered expression and activation of proinflammatory and profibrotic genes, to increase production of ROS and ultimately contribute to the development of NASH and cirrhosis.
“Byproducts of incomplete fatty acid oxidation could act in concert with adipose tissue-derived inflammatory signals (e.g., TNF␣), and altered expression and activation of proinflammatory (e.g., IL-1R family) and profibrotic genes (e.g., TGFB1, FGFR2), to increase production of ROS and ultimately contribute to the development of NASH and cirrhosis (235).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [235] Sanyal, 2001, Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities., Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationIn the first study, severe obesity (mean BMI 52 kg/m2) was associated with reduced expression of seven of 25 genes encoding OXPHOS genes; expression of these genes was inversely correlated with hepatic lipid accumulation and paralleled by reduced expression of PGC-1α and genes known to be regulated by thyroid hormone.
“In the first (232), severe obesity (mean BMI 52 kg/m 2 ) was associated with reduced ex-pression of seven of 25 genes encoding OXPHOS genes; expression of these genes was inversely correlated with hepatic lipid accumulation and paralleled by reduced expression of PGC-1␣ and genes known to be regulated by thyroid hormone.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [232] Pihlajamäki, 2009, Thyroid hormone-related regulation of gene expression in human fatty liver., J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationReduced expression of OXPHOS genes (e.g., COX7C, ATP5C1) was also observed in mice fed a high-fat diet and normalized by acute therapy with thyroid hormone T3, suggesting that functional hepatic thyroid hormone resistance could contribute to reduced expression of mitochondrial oxidative genes in this context.
“Interestingly, reduced expression of OXPHOS genes (e.g., COX7C, ATP5C1) was also observed in mice fed a high-fat diet and normalized by acute therapy with thyroid hormone T 3suggesting that functional hepatic thyroid hormone resistance could contribute to reduced expression of mitochondrial oxidative genes in this context (232).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [232] Pihlajamäki, 2009, Thyroid hormone-related regulation of gene expression in human fatty liver., J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationAccumulation of lipid within hepatocytes is a key marker of insulin resistance in humans and a major contributor to nonalcoholic fatty liver disease, nonalcoholic steatohepatitis (NASH), and cirrhosis.
“Because accumulation of lipid within hepatocytes is a key marker of insulin resistance in humans (207) and a major contributor to nonalcoholic fatty liver disease, nonalcoholic steatohepatitis (NASH), and cirrhosis, we will first consider relationships between hepatic lipid metabolism and insulin resistance, and in Section III.C.3 will review evidence linking DM and hepatic steatosis to”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [207] Kotronen, 2008, Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome., Diabetologia source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenWith aging, chronic ROS exposure, and/or the development of insulin resistance related to obesity or sustained lipid accumulation, OXPHOS expression may fall.
“With aging, chronic ROS exposure, and/or the development of insulin resistance related to obesity or sustained lipid accumulation, OXPHOS expression may fall.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMice with hepatic insulin resistance due to deletions of the major insulin receptor substrates (IRS-1 and IRS-2) have impaired mitochondrial function and biogenesis, as demonstrated by reduced NADH oxidation, reduced ATP production rates, reduced numbers of mitochondria per cell, reduced fatty acid oxidation, and increased hepatic triglyceride accumulation.
“Indeed, a recent paper demonstrated that mice with hepatic insulin resistance due to deletions of the major insulin receptor substrates (IRS-1 and IRS-2) have impaired mitochondrial function and biogenesis, as demonstrated by reduced NADH oxidation, reduced ATP production rates, reduced numbers of mitochondria per cell, reduced fatty acid oxidation, and increased hepatic triglyceride accumulation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Cheng, 2009, Foxo1 integrates insulin signaling with mitochondrial function in the liver., Nat Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S4 (based). May combine two claims.
Interpretationnone givenModest obesity may be associated with compensatory up-regulation of OXPHOS gene expression in response to sustained lipid load and/or functional defects in complete fatty acid oxidation.
“We hypothesize that modest obesity may be associated with compensatory up-regulation of OXPHOS gene expression in response to sustained lipid load and/or functional defects in complete fatty acid oxidation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningAlthough this may be an appropriate response, limiting oxidative stress, it may also contribute to a vicious cycle of further impairments in oxidative capacity, increased lipid accumulation, and progressive insulin resistance.
“Although this may be an appropriate response, limiting oxidative stress, it may also contribute to a vicious cycle of further impairments in oxidative capacity, increased lipid accumulation, and progressive insulin resistance.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTransgenic mice expressing lipoprotein lipase in the liver have a 2-fold increase in hepatic triglyceride content and are insulin resistant.
“Transgenic mice expressing lipoprotein lipase in the liver have a 2-fold increase in hepatic triglyceride content and are insulin resistant (219).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [219] Kim, 2001, Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
InterpretationcitationFatty acid-induced reductions in insulin receptor number and function in the liver may also reduce hepatic insulin clearance, causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function.
“Fatty acid-induced reductions in insulin receptor number and function in the liver (211) may also reduce hepatic insulin clearance (226), causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function (214,227,228).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [211] Benard, 2006, Physiological diversity of mitochondrial oxidative phosphorylation, Am J Physiol Cell Physiol source
Not checked in the free run.
- cites [226] Seppälä-Lindroos, 2002, Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men., J Clin Endocrinol Metab source
Not checked in the free run.
- cites [214] Kotronen, 2008, Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes., Gastroenterology source
Not checked in the free run.
- cites [227] Park, 2006, Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [228] Liu, 2009, Prolonged exposure to insulin suppresses mitochondrial production in primary hepatocytes., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationHepatic lipid accumulation is associated with obesity in humans, particularly central (abdominal) in location, and in parallel with low adiponectin levels.
“Although the relative roles of each of these possibilities is incompletely understood, hepatic lipid accumulation is associated with obesity in humans, particularly central (abdominal) in location (214, 215), and in parallel with low adiponectin levels (216).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [214] Kotronen, 2008, Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes., Gastroenterology source
Not checked in the free run.
- cites [215] Petersen, 2005, Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes., Diabetes source
Not checked in the free run.
- cites [216] Koska, 2008, Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals., Am J Clin Nutr source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationcitationExcessive hepatic lipid accumulation may play a central, pathogenic role in insulin resistance.
“One possibility is that excessive hepatic lipid accumulation may play a central, pathogenic role in insulin resistance.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEnzymatic activity of complexes I-V is reduced in liver extracts from patients with NASH and is inversely correlated with BMI and HOMA-IR.
“Indeed, enzymatic activity of complexes I-V is reduced in liver extracts from patients with NASH and is inversely correlated with BMI and HOMA-IR (233, 234).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [233] Pérez-Carreras, 2003, Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis., Hepatology source
Not checked in the free run.
- cites [234] Greenfield, 2008, Recent advances in nonalcoholic fatty liver disease., Curr Opin Gastroenterol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSeveral differences in study population may account for the discordant findings between the two data sets: much greater degree of adiposity and hepatic steatosis in the first; differences in ethnicity (Caucasian-Americans vs. Japanese); and differences in insulin sensitivity and glycemia.
“Although these two data sets appear to be discordant (i.e., obesity-linked down-regulation of mitochondrial oxidative gene expression in the first, and up-regulation in the second), several differences in the study population may account for these findings: 1) much greater degree of adiposity and hepatic steatosis in the first; 2) differences in ethnicity (Caucasian-Americans vs. Japanese); and 3)”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationUp-regulation of these OXPHOS genes was also positively associated with expression of several genes linked to mitochondrial biogenesis (e.g., PGC-1β, ERRα, NRF, thyroid hormone receptor) and both ROS generation (e.g., NADPH oxidase) and attenuation (e.g., glutathione peroxidase).
“Up-regulation of these OXPHOS genes was also positively associated with expression of several genes linked to mitochondrial biogenesis (e.g., PGC-1, ERR␣, NRF, thyroid hormone receptor) and both ROS generation (e.g., NADPH oxidase) and attenuation (e.g., glutathione peroxidase).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [231] Takamura, 2008, Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients., Obesity (Silver Spring) source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial diabetes only develops upon aging, with an average age of onset between 35 and 40 years for MIDD and 48 years for the 14577 T>C mutation.
“Interestingly, mitochondrial diabetes only develops upon aging, with an average age of onset between 35 and 40 yr for MIDD and 48 yr for 14577 TϾC.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Maassen, 2004, Mitochondrial diabetes: molecular mechanisms and clinical presentation, Diabetes source
Not checked in the free run.
May combine two claims.
InterpretationreasoningActivation of UCP2 leads to decreased ATP production, which impairs insulin secretion.
“However, it also leads to decreased ATP production, which impairs insulin secretion.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn the presence of excess FFA, the normal feedback loop is compromised by direct activation of UCP2 by FFA, as well as an effect of FFA to increase the amount of UCP2.
“B, In the presence of excess FFA, this normal feedback loop is compromised by a direct activation of UCP2 by FFA, as well as an effect of FFA to increase the amount of UCP2.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLow levels of ROS are necessary for insulin secretion, but chronic, high mitochondrial ROS production can have a deleterious effect on β-cell function.
“Low levels of ROS are necessary for insulin secretion, but chronic, high mitochondrial ROS production can have a deleterious effect on -cell function (254 -256).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [254] Li, 2008, The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress., Biochem Soc Trans source
Not checked in the free run.
- cites [255] Rachek, 2006, Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria., Diabetes source
Not checked in the free run.
- cites [256] Simmons, 2005, Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to β-cell failure., J Biol Chem source
Not checked in the free run.
May combine two claims.
InterpretationreasoningUCPs must uncouple respiration sufficiently to mitigate toxic levels of ROS, but not enough to decrease ATP and ROS below the levels necessary for insulin secretion.
“Thus, UCPs must uncouple respiration sufficiently to mitigate toxic levels of ROS, but not enough to decrease ATP and ROS below the levels necessary for insulin secretion.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThese same animals displayed increased liver gluconeogenic enzyme levels and impaired insulin suppression of hepatic glucose production, thus nullifying the potentially beneficial effect of modest muscle PGC-1α overexpression on whole-body glucose homeostasis.
“However, these same animals displayed increased liver gluconeogenic enzyme levels and impaired insulin suppression of hepatic glucose production, thus nullifying the potentially beneficial effect of modest muscle PGC-1␣ overexpression on whole-body glucose homeostasis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationClonal cytosolic hybrid cells harboring mitochondria derived from MIDD patients exhibit impaired calcium handling and elevated ROS under metabolic stress.
“Consistent with this view, clonal cytosolic hybrid cells harboring mitochondria derived from MIDD patients exhibit impaired calcium handling and elevated ROS under metabolic stress (247, 248).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [247] Maechler, 2006, In β-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion., Int J Biochem Cell Biol source
Not checked in the free run.
- cites [248] Andrade, 2006, Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for β-cell function., Diabetologia source
Not checked in the free run.
May combine two claims.
PremisecitationOverexpression of PGC-1α in myotubes causes approximately 2-fold increases in mtDNA and oxygen consumption and a 50% increase in mitochondrial density.
“PGC-1␣ and related coactivators are critical for the regulation of mitochondrial oxidative capacity, as demonstrated by the approximately 2-fold increases in mtDNA and oxygen consumption and a 50% increase in mitochondrial density in myotubes overexpressing PGC-1␣ (56).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1., Cell source
Not checked in the free run.
May combine two claims.
Premisecitationβ-cell specific deletion of Tfam reduces insulin secretory capacity and β-cell mass, yielding so-called mitochondrial DM.
“Consistent with this possibility, -cell specific deletion of Tfam reduces insulin secretory capacity and -cell mass, yielding so-called mitochondrial DM (241).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [241] Silva, 2000, Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes., Nat Genet source
Not checked in the free run.
May combine two claims.
InterpretationcitationChronically increased ROS production can induce β-cell death and result in gradual onset of diabetes.
“Chronically increased ROS production could also induce -cell death and result in gradual onset of diabetes (249 -253).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [249] Hou, 2008, Reactive oxygen species-mediated pancreatic β-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases., Endocrinology source
Not checked in the free run.
- cites [250] Lim, 2008, Induction of apoptosis of β-cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus., Ann NY Acad Sci source
Not checked in the free run.
- cites [251] Newsholme, 2007, Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity., J Physiol source
Not checked in the free run.
- cites [252] Nishikawa, 2007, Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications., Antioxid Redox Signal source
Not checked in the free run.
- cites [253] Robertson, 2009, β-Cell deterioration during diabetes: what’s in the gun?, Trends Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial metabolism is also required for the transient, controlled production of ROS, which is required for the mitochondrial signaling pathways that trigger granule exocytosis.
“Mitochondrial metabolism is also required for the transient, controlled production of ROS, which is required for the mitochondrial signaling pathways that trigger granule exocytosis (239, 240).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [239] Evans, 2003, Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?, Diabetes source
Not checked in the free run.
- cites [240] Leloup, 2009, Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion., Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationIn these animals, mitochondrial density and OXPHOS gene expression are more than double basal levels, and large increases in UCP2 gene expression are observed.
“In these animals, mitochondrial density and OXPHOS gene expression are more than double basal levels, and large increases in UCP2 gene expression are also observed.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [263] Miura, 2003, Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles., J Biol Chem source
Not checked in the free run.
- cites [264] Miura, 2006, Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP., Am J Pathol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMitochondrial dysfunction in β-cells would be expected to reduce insulin secretion and thus promote the development of DM.
“Given the crucial role of mitochondrial ATP generation, anaplerosis, and ROS production in insulin secretion, mitochondrial dysfunction in -cells would be expected to reduce insulin secretion and thus promote the development of DM.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBoth rapid (first phase) and more prolonged (second phase) insulin secretion are dependent on glucose metabolism and mitochondrial oxidative capacity.
“Both rapid (first phase) and more prolonged (second phase) insulin secretion (237) are dependent on glucose metabolism and mitochondrial oxidative capacity; glucose oxidation increases the ATP/ADP ratio, inhibiting plasma membrane K-ATP channels and allowing voltage-gated calcium channels to open.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [237] O'Connor, 1980, Comparison of storage- and signal-limited models of pancreatic insulin secretion, Am J Physiol
Not checked in the free run.
May combine two claims.
PremisecitationTransgenic mice expressing human PGC-1α driven by its own promoter displayed a modest (30% higher than basal) increase in mRNA expression of several OXPHOS genes, fiber type switching, and enhanced muscle insulin sensitivity.
“Similarly, transgenic mice expressing human PGC-1␣ driven by its own promoter displayed a modest (30% higher than basal) increase in mRNA expression of several OXPHOS genes, fiber type switching, and enhanced muscle insulin sensitivity (262).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationThe lowest level of PGC-1α overexpression in rat muscle by electroporation resulted in modest up-regulation of mitochondrial proteins, increased palmitate oxidation, and increased insulin-stimulated glucose uptake.
“The lowest level of PGC-1␣ overexpression was achieved in rat muscle by means of electroporation (261).This resulted in modest up-regulation of mitochondrial proteins, increased palmitate oxidation, and increased insulin-stimulated glucose uptake.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [261] Benton, 2008, Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationIn hybrid cell lines derived from probands with the 14577 T>C mutation, mitochondrial respiratory chain complex I activity and O2 consumption rates are decreased by 65 and 62%, respectively.
“In this case, mitochondrial respiratory chain complex I activity and O 2 consumption rates are decreased by 65 and 62%, respectively, in hybrid cell lines derived from probands.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [245] Tawata, 2000, A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes., Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationThis modest PGC-1α overexpression was accompanied by decreased levels of ROS and inflammatory signaling.
“Importantly, this modest PGC-1␣ overexpression also was accompanied by decreased levels of ROS and inflammatory signaling.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisereasoningMitochondrial function in β-cells is highly regulated by the levels and activities of UCPs, which are in turn regulated by ROS produced by the activity of the ETC.
“Mitochondrial function in -cells is highly regulated by the levels and activities of UCPs, in turn regulated by ROS produced by the activity of the ETC.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe levels and activity of UCP2 and the rate of ROS production are both increased by high-fat diet and hyperphagia, possibly through the actions of nonesterified fatty acids and their ceramide derivatives.
“The levels and activity of UCP2 and the rate of ROS production are both increased by high-fat diet and hyperphagia, possibly through the actions of nonesterified fatty acids and their ceramide derivatives (260).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [260] Koshkin, 2003, Mitochondrial functional state in clonal pancreatic β-cells exposed to free fatty acids., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationDespite these effects, insulin sensitivity is normal in PGC-1α transgenic mice fed a chow diet and is reduced during high-fat feeding.
“Despite these effects, insulin sensitivity is normal in PGC-1␣ transgenic mice fed a chow diet and, surprisingly, is reduced during high-fat feeding.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [267] Calvo, 2008, Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake., J Appl Physiol source
Not checked in the free run.
- cites [268] Lin, 2002, Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibers., Nature source
Not checked in the free run.
- cites [269] Sandri, 2006, PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
PremisecitationInducible overexpression of PGC-1α in skeletal muscle results in increased mitochondrial density and a robust increase in expression of OXPHOS genes and genes necessary for fatty acid oxidation.
“Inducible overexpression of PGC-1␣ in skeletal muscle ( 265) results in increased mitochondrial density and a robust increase in expression of OXPHOS genes and genes necessary for fatty acid oxidation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [265] Wende, 2007, A role for the transcriptional coactivator PGC-1α in muscle refueling., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationWhole-body transgenic overexpression of PGC-1β resulted in increased oxidative metabolism, protection from obesity induced by high-fat diet or hyperphagia, and enhanced insulin sensitivity.
“Consistent with these findings, whole-body transgenic overexpression of PGC-1 resulted in increased oxidative metabolism, protection from obesity induced by high-fat diet or hyperphagia, and enhanced insulin sensitivity (272).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [272] Kamei, 2003, PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough low-intensity exercise performance did not differ in this model, high-performance exercise was impaired, in parallel with failure to mobilize stored glycogen.
“Although low-intensity exercise performance did not differ in this model, high-performance exercise was impaired, in parallel with failure to mobilize stored glycogen.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [265] Wende, 2007, A role for the transcriptional coactivator PGC-1α in muscle refueling., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationIn adults, PGC-1α induction led to a more modest mitochondrial proliferation, which was nevertheless accompanied by cardiomyopathy.
“In adults, PGC-1␣ induction led to a more modest mitochondrial proliferation, which was nevertheless surprisingly accompanied by cardiomyopathy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [266] Russell, 2004, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner., Circ Res source
Not checked in the free run.
May combine two claims.
PremisecitationFunctionally, whole-body PGC-1α-null mice show decreases in ATP levels, state 3 respiration, and metabolic efficiency, and cardiac and skeletal muscle performance is reduced in response to stress.
“Functionally, decreases in ATP levels, state 3 respiration, and metabolic efficiency are seen, and cardiac and skeletal muscle performance is reduced in response to stress.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [61] Lehman, 2008, The transcriptional coactivator PGC-1α is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis, Am J Physiol Heart Circ Physiol source
Not checked in the free run.
- cites [67] Leone, 2005, PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis, PLoS Biol source
Not checked in the free run.
- cites [68] Arany, 2005, Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle., Cell Metab source
Not checked in the free run.
- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIn this model, ATP synthesis rate and exercise performance are increased, and fatty acid oxidation is also enhanced.
“In this model, ATP synthesis rate and exercise performance are increased, and fatty acid oxidation is also enhanced.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [267] Calvo, 2008, Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake., J Appl Physiol source
Not checked in the free run.
- cites [268] Lin, 2002, Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibers., Nature source
Not checked in the free run.
- cites [269] Sandri, 2006, PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
PremisecitationMuscle function appears compromised in these animals, as evidenced by decreased voluntary exercise, muscle atrophy, and decreased insulin sensitivity.
“Muscle function appears compromised, as evidenced by decreased voluntary exercise, muscle atrophy, and decreased insulin sensitivity.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [263] Miura, 2003, Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles., J Biol Chem source
Not checked in the free run.
- cites [264] Miura, 2006, Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP., Am J Pathol source
Not checked in the free run.
May combine two claims.
InterpretationcitationModest overexpression of PGC-1α and transgenic overexpression of PGC-1β increase oxidative metabolism and insulin sensitivity.
“Taken together, these studies suggest that modest overexpression of PGC-1␣ (261, 262) and transgenic overexpression of PGC-1 (271, 272) increase oxidative metabolism and insulin sensitivity.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [261] Benton, 2008, Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria., J Biol Chem source
Not checked in the free run.
- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [271] Arany, 2007, The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle., Cell Metab source
Not checked in the free run.
- cites [272] Kamei, 2003, PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity., Proc Natl Acad Sci USA source
Not checked in the free run.
May combine two claims.
PremisecitationMuscle-specific transgenic overexpression of PGC-1β results in increased oxidative fiber content and increased expression of OXPHOS and multiple other mitochondrial genes.
“Muscle-specific transgenic overexpression of PGC-1 results in increased oxidative fiber content and increased expression of OXPHOS and multiple other mitochondrial genes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [271] Arany, 2007, The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle., Cell Metab source
Not checked in the free run.
May combine two claims.
InterpretationcitationHigh-level overexpression of PGC-1α may reduce insulin sensitivity via reduced glycolysis and/or glucose oxidation or myofibrillar disruption/myopathy, potentially limiting exercise tolerance.
“By contrast, highlevel overexpression of PGC-1␣ may actually reduce insulin sensitivity via reduced glycolysis and/or glucose oxidation (265) or myofibrillar disruption/myopathy, potentially limiting exercise tolerance.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [265] Wende, 2007, A role for the transcriptional coactivator PGC-1α in muscle refueling., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationIn these animals, both muscle glucose uptake and glycogen deposition were increased.
“In these animals, both muscle glucose uptake and glycogen deposition were increased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [265] Wende, 2007, A role for the transcriptional coactivator PGC-1α in muscle refueling., J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationWhen higher levels of PGC-1α overexpression are restricted to heart during early life, increased neonatal mitochondrial proliferation is observed, but it is accompanied by myofibrillar displacement.
“When higher levels of PGC-1␣ overexpression are restricted to heart during early life (266), increased neonatal mitochondrial proliferation is observed, but it is accompanied by myofibrillar displacement.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [266] Russell, 2004, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner., Circ Res source
Not checked in the free run.
May combine two claims.
PremisecitationWhole-body PGC-1α-null mice consistently display 30-60% reductions in OXPHOS gene expression in muscle, normal to decreased mitochondrial density in skeletal muscle, and decreased cristae density in heart.
“These mice consistently display 30 -60% reductions in OXPHOS gene expression in muscle, normal to decreased mitochondrial density in skeletal muscle, and decreased cristae density in heart.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [61] Lehman, 2008, The transcriptional coactivator PGC-1α is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis, Am J Physiol Heart Circ Physiol source
Not checked in the free run.
- cites [67] Leone, 2005, PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis, PLoS Biol source
Not checked in the free run.
- cites [68] Arany, 2005, Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle., Cell Metab source
Not checked in the free run.
- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial energetics are impaired in these animals, with 60% decreases in ATP levels in muscle homogenates and concomitant increases in AMP kinase activation.
“Mitochondrial energetics are impaired, with 60% decreases in ATP levels in muscle homogenates and concomitant increases in AMP kinase activation, probably as a compensatory response to decreased mitochondrial functionality.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [263] Miura, 2003, Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles., J Biol Chem source
Not checked in the free run.
- cites [264] Miura, 2006, Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP., Am J Pathol source
Not checked in the free run.
May combine two claims.
PremisecitationIn cultured myotubes overexpressing PGC-1α, lipid content is decreased in the serum-starved condition, reflecting increased oxidation of lipids; in the serum-replete state, intracellular fatty acid levels are increased, likely due to both increased de novo fatty acid synthesis from glucose and fatty acid synthesis by chain elongation.
“For example, in cultured myotubes overexpressing PGC-1␣ (273), lipid content is decreased in the serum-starved condition, reflecting increased oxidation of lipids; by contrast, in the serum-replete state, intracellular fatty acid levels are increased, likely due to both increased de novo fatty acid synthesis from glucose and fatty acid synthesis by chain elongation (273).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] Espinoza, 2009
Not checked in the free run.
May combine two claims.
PremisecitationDouble PGC-1α and PGC-1β muscle-specific knockout mice display normal mitochondrial biogenesis during development but die early after birth due to failure of perinatal mitochondrial proliferation and consequent cardiac failure.
“These animals display normal mitochondrial biogenesis during development but die early after birth due to failure of perinatal mitochondrial proliferation and consequent cardiac failure (62).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Lai, 2008, Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart., Genes Dev source
Not checked in the free run.
May combine two claims.
PremisecitationIn these mice, insulin sensitivity is normal and glucose tolerance is enhanced, consistent with a need for enhanced fuel utilization in response to inefficient mitochondrial ATP production.
“In these mice, insulin sensitivity is normal and glucose tolerance is enhanced, consistent with a need for enhanced fuel utilization in response to inefficient mitochondrial ATP production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [282] Wang, 1999, Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression., Nat Genet source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1β-null mice have more striking hepatic phenotypes, with hepatic insulin resistance, even on normal chow, and steatosis with high-fat feeding.
“PGC-1-null mice have more striking hepatic phenotypes, with hepatic insulin resistance, even on normal chow, and steatosis with high-fat feeding (59,65,66).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [59] Sonoda, 2007, PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [65] Vianna, 2006, Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance., Cell Metab source
Not checked in the free run.
- cites [66] Lelliott, 2006, Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol source
Not checked in the free run.
May combine two claims.
PremisecitationSkeletal and cardiac muscle-specific deletion of Tfam causes severe OXPHOS deficits, dilated cardiomyopathy, and death during early postnatal life.
“Similarly, skeletal and cardiac muscle-specific deletion of Tfam causes severe OXPHOS deficits, dilated cardiomyopathy, and death during early postnatal life (282).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [282] Wang, 1999, Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression., Nat Genet source
Not checked in the free run.
May combine two claims.
PremisecitationTissue-specific ablation of AIF produced modest defects in respiratory chain gene expression and function; both muscle- and liver-specific null mice had increased insulin sensitivity, reduced fat mass, and improved glucose tolerance.
“Pospisilik et al. (274) used an alternative strategy to test whether experimentally induced respiratory chain complex deficiency would induce metabolic phenotypes.Tissue-specific ablation of the nuclear-encoded gene, mitochondrial apoptosis-inducing factor (AIF), produced modest defects in respiratory chain gene expression and function, as expected; however, both muscle-and liverspecific null mice”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [274] Pospisilik, 2007, Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes., Cell source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1β-null mice display phenotypes similar to, but not identical to, those of PGC-1α knockouts, including reduced expression of OXPHOS genes, reduced ATP synthesis, reduced exercise capacity, and impaired thermogenesis.
“PGC-1-null mice (59, 62, 65, 66) display phenotypes similar to, but not identical to, those of PGC-1␣ knockouts, including reduced expression of OXPHOS genes, reduced ATP synthesis, reduced exercise capacity, and impaired thermogenesis (59,62).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [59] Sonoda, 2007, PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [62] Lai, 2008, Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart., Genes Dev source
Not checked in the free run.
- cites [65] Vianna, 2006, Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance., Cell Metab source
Not checked in the free run.
- cites [66] Lelliott, 2006, Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningPGC-1α and PGC-1β are both required for the full complement of OXPHOS gene expression, the establishment of correct fuel partitioning, and optimal metabolic efficiency.
“PGC-1␣ and PGC-1 are both required for the full complement of OXPHOS gene expression, the establishment of correct fuel partitioning, and optimal metabolic efficiency because whole-body and tissue-specific knockout of either of these genes leads to deranged multiorgan metabolic phenotypes that are more evident during energetic stress.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTfam is essential for transcription of mtDNA and thus mitochondrial development, as indicated by the embryonic lethality of Tfam-null mice.
“The nuclearencoded mitochondrial transcription factor Tfam is essential for transcription of mtDNA and thus mitochondrial development, as indicated by the embryonic lethality of Tfam-null mice (281).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [281] Larsson, 1998, Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice., Nat Genet source
Not checked in the free run.
May combine two claims.
InterpretationreasoningLack of PGC-1α per se does not lead to insulin resistance, despite clear alterations in muscle and metabolic phenotypes.
“Thus, lack of PGC-1␣ per se does not lead to insulin resistance, despite clear alterations in muscle and metabolic phenotypes.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningDespite pronounced muscle and brown adipose tissue functional impairments in PGC-1α deficiency, mitochondrial density in muscle and brown adipose tissue is not notably decreased, indicating a possible compensatory role of PGC-1β in mitochondrial biogenesis.
“Despite pronounced muscle and brown adipose tissue functional impairments seen in models of PGC-1␣ deficiency, mitochondrial density in muscle and brown adipose tissue is not notably decreased, indicating the possible compensatory role of PGC-1 in mitochondrial biogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSkeletal muscle-specific Tfam deficiency is accompanied by increased AMP kinase activation and increased glycolysis, indicating that compensatory mechanisms to maintain ATP levels are activated in response to impaired mitochondrial energetics.
“Skeletal muscle-specific Tfam deficiency is accompanied by increased AMP kinase activation and increased glycolysis, indicating that compensatory mechanisms to maintain ATP levels are activated in response to impaired mitochondrial energetics (282).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [282] Wang, 1999, Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression., Nat Genet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationERRγ interacts with PGC-1 to regulate expression of ERRα.
“Although the physiological effects of the related gene ERR␥ remain unclear, it interacts with PGC-1 to regulate expression of ERR␣ (278), and polymorphisms at this locus were found to be associated with increased glucose area under the curve in a genetic analysis of Old Order Amish subjects (279).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [278] Liu, 2005, Estrogen-related receptor-γ and peroxisome proliferator-activated receptor-γ coactivator-1α regulate estrogen-related receptor-α gene expression via a conserved multi-hormone response element., J Mol Endocrinol source
Not checked in the free run.
May combine two claims.
PremisecitationERRα-null mice have reduced body weight and are normoglycemic, in parallel with up-regulation of medium-chain acyl-CoA dehydrogenase and reduced lipogenesis, both of which may contribute to resistance to diet-induced obesity.
“Interestingly, ERR␣-null mice have reduced body weight and are normoglycemic, in parallel with up-regulation of medium-chain acyl-CoA dehydrogenase and reduced lipogenesis, both of which may contribute to resistance to diet-induced obesity (277).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [277] Luo, 2003, Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α., Mol Cell Biol source
Not checked in the free run.
May combine two claims.
PremisecitationBoth lines of whole-body PGC-1α knockout animals display cold sensitivity, likely related to impaired mitochondrial function in brown adipose tissue.
“In addition, both lines of whole-body PGC-1␣ knockout animals display cold sensitivity, likely related to impaired mitochondrial function in brown adipose tissue (67, 69) (Table 2).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Leone, 2005, PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis, PLoS Biol source
Not checked in the free run.
- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenSuch alterations in mitochondrial activity could be mediated by genetic factors (family history, ethnicity), epigenetic mechanisms, developmental exposures, and aging.
“In turn, such alterations in mitochondrial activity could be mediated by genetic factors (family history, ethnicity), epigenetic mechanisms, developmental exposures, and aging.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIndividuals with low oxidative capacity and/or suboptimal adaptive responses would be intolerant to moderate-high fuel loads, leading to lipid accumulation, incomplete oxidation, production of ROS, and acute insulin resistance.
“Conversely, individuals with low oxidative capacity and/or subopti-mal adaptive responses would be intolerant to moderatehigh fuel loads, leading to lipid accumulation, incomplete oxidation, production of ROS, and acute insulin resistance (Fig. 5B).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPGC-1β whole-body knockout reduced mitochondrial DNA by 20% and OXPHOS mRNA by 20-40% (Lelliot, 2006).
“Lelliot, 2006 PGC-1 whole-body KO 2 20% 20 -40% 2 mRNA | (66)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Lelliott, 2006, Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningResults from multiple mouse models now indicate that absolute deficiency of the PGC-1 family of coactivators or mitochondrial OXPHOS per se does not directly produce insulin resistance.
“Nevertheless, results from multiple mouse models now indicate that absolute deficiency of the PGC-1 family of coactivators or mitochondrial OXPHOS per se does not directly produce insulin resistance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenDNA polymerase γ is a mtDNA polymerase critical for maintenance of mtDNA.
“DNA polymerase ␥ is a mtDNA polymerase critical for maintenance of mtDNA.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAn individual's intrinsic mitochondrial oxidative activity may determine the magnitude of chronic cellular dysfunction and influence adaptive responses to chronic fuel excess, as with obesity or inactivity.
“Thus, we interpret the current data to indicate that an individual's intrinsic mitochondrial oxidative activity may determine the magnitude of chronic cellular dysfunction and influence adaptive responses to chronic fuel excess, as with obesity or inactivity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationMild deficiencies in mitochondrial activity, and/or an inability to increase activity and capacity in response to cellular energy demand, could explain the reduced exercise ability seen in individuals with a family history of DM.
“With regard to the first question, mild deficiencies in mitochondrial activity, and/or an inability to increase activity and capacity in response to cellular energy demand, could explain the reduced exercise ability seen in individuals with a family history of DM (106).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [106] Kacerovsky-Bielesz, 2009, Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes., Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α whole-body knockout reduced mitochondrial DNA by 30% and OXPHOS mRNA by 40-60% (Leone, 2005).
“Leone, 2005 PGC-1␣ whole-body KO 30% 2 40 -60% 2 mRNA | (67)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Leone, 2005, PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis, PLoS Biol source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α transgenic expression increases OXPHOS mRNA and protein levels, with increases ranging from 130% to 500% across transgenic models.
“180% 1 COXIV | protein | 130% 1 mRNA | | 150 -200% | 1 mRNA | | | 150 -250% | 1 mRNA | | | | 170 -300% | 1 mRNA | 200 -500% | 1 mRNA and | protein”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [261] Benton, 2008, Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria., J Biol Chem source
Not checked in the free run.
- cites [262] Liang, 2009, Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [263] Miura, 2003, Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles., J Biol Chem source
Not checked in the free run.
- cites [264] Miura, 2006, Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP., Am J Pathol source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α whole-body knockout results in normal mitochondrial DNA but reduced OXPHOS mRNA by 30-60% and cytochrome C protein by 50% (Lin, 2004; Arany, 2005).
“Lin, 2004 (69); PGC-1␣ whole-body KO Normal 30 -60% 2 mRNA; | Arany, 50% 2 CytC | 2005 (68) protein”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [69] Lin, 2004, Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice., Cell source
Not checked in the free run.
- cites [68] Arany, 2005, Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle., Cell Metab source
Not checked in the free run.
May combine two claims.
InterpretationreasoningExcessive ROS can induce both insulin resistance and mitochondrial dysfunction.
“In turn, excessive ROS can induce both insulin resistance and mitochondrial dysfunction.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
InterpretationreasoningWith time, mitochondrial damage ensues, further exacerbating the impairment of oxidative capacity.
“With time, mitochondrial damage ensues, further exacerbating the process.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExposure of muscle cells in vitro to saturated fatty acids or high-fat feeding in mice results in alterations in mitochondrial structure and insulin resistance, both of which are reversed by antioxidants.
“Similarly, exposure of muscle cells in vitro to saturated fatty acids or high-fat feeding in mice results in alterations in mitochondrial structure and insulin resistance, both of which are reversed by antioxidants (286 -288).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [286] Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts., Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [287] Anderson, 2009, Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart., J Am Coll Cardiol source
Not checked in the free run.
- cites [288] Bonnard, 2008, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice., J Clin Invest
Not checked in the free run.
May combine two claims.
InterpretationreasoningTogether, these factors contribute to progressively impaired insulin sensitivity, insulin secretion, and heightened risk of DM.
“Together, these factors contribute to progressively impaired insulin sensitivity, insulin secretion, and heightened risk of DM.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenChronic fuel excess, in the setting of suboptimal oxidative activity, results in fatty acid accumulation, incomplete oxidation, increased oxidative stress, and ROS generation, leading to impairment in oxidative capacity.
“Chronic fuel excess, in the setting of suboptimal oxidative activity, results in fatty acid accumulation, incomplete oxidation, increased oxidative stress, and ROS generation leading to impairment in oxidative capacity, compounding the deleterious effects of fuel excess.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningFailure of complete oxidation can lead to accumulation of lipid intermediates, incomplete fatty acid oxidation products, and ROS, inducing both insulin resistance (muscle, liver, adipose) and altered secretion (β-cells).
“Failure of complete oxidation can lead to accumulation of lipid intermediates, incomplete fatty acid oxidation products, and ROS, inducing both insulin resistance (muscle, liver, adipose) and altered secretion (-cells).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningOxidative stress can induce mitochondrial dysfunction in parallel with insulin resistance-perhaps an adaptive response aimed at limiting further oxidative damage.
“Thus, oxidative stress can induce mitochondrial dysfunction in parallel with insulin resistance-perhaps an adaptive response aimed at limiting further oxidative damage.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningResulting lipid accumulation and oxidative stress can alter transcriptional responses and damage mitochondria, further reducing OXPHOS capacity, compounding the deleterious effects of fuel excess and increasing diabetes risk.
“Resulting lipid accumulation and oxidative stress can alter transcriptional responses and damage mitochondria, further reducing OXPHOS capacity, compounding the deleterious effects of fuel excess and increasing diabetes risk.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMice null for the mitochondrial helicase Twinkle have impaired respiratory chain activity and muscle atrophy, but no defect in exercise capacity.
“Mice null for the mitochondrial helicase Twinkle have impaired respiratory chain activity and muscle atrophy, but no defect in exercise capacity (285).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [285] Tyynismaa, 2004, Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number., Hum Mol Genet source
Not checked in the free run.
May combine two claims.
InterpretationreasoningWith time, insufficient oxidative capacity could be resolved by compensatory mechanisms that increase oxidative capacity or decrease fuel load; insufficient compensation could result in chronic insulin resistance.
“With time, insufficient oxidative capacity could be resolved by compensatory mechanisms that increase oxidative capacity (e.g., exercise, mitochondrial biogenesis) (Fig. 5C, top right) or decrease fuel load (weight loss) (Fig. 5C, middle right).Insufficient compensation could result in chronic insulin resistance (Fig. 5C, bottom right).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAn individual's intrinsic mitochondrial oxidative capacity is determined by numerous factors including genetic and ethnic background, intrauterine exposures, and age.
“An individual's intrinsic mitochondrial oxidative capacity is determined by numerous factors including genetic and ethnic background, intrauterine exposures, and age.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningOver time, this phenotype could contribute to reduced voluntary exercise and increase the likelihood of an imbalance between mitochondrial activity and fatty acid load.
“Over time, this phenotype could contribute to reduced voluntary exercise and increase the likelihood of an imbalance between mitochondrial activity and fatty acid load.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPGC-1α muscle-specific knockout results in normal mitochondrial DNA but reduced OXPHOS mRNA by 30-40% (Handschin, 2007).
“Handschin, PGC-1␣ muscle-specific Normal 30 -40% 2 mRNA | 2007 KO | (63, 64)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals., J Biol Chem source
Not checked in the free run.
- cites [64] Handschin, 2007, Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β-cell crosstalk., J Clin Invest source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1β whole-body hypomorph reduced mitochondrial DNA by 30% and OXPHOS mRNA by 20-30% (Vianna, 2006).
“Vianna, 2006 PGC-1 whole-body 2 30% 20 -30% 2 mRNA | (65) hypomorph”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Vianna, 2006, Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance., Cell Metab source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1β whole-body hypomorph results in normal mitochondrial DNA but reduced OXPHOS mRNA by 30-40% (Sonoda, 2007).
“Sonoda, 2007 PGC-1 whole-body Normal 30 -40% 2 mRNA | (59) hypomorph”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Sonoda, 2007, PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis., Proc Natl Acad Sci USA source
Not checked in the free run.
The paper relies on this without support.
Skeletal muscle accounts for more than 80% of insulin-stimulated glucose disposal in humans.
“Skeletal muscle is the largest insulin-sensitive organ in humans, accounting for more than 80% of insulinstimulated glucose disposal.”
The paper relies on this without support.
Mitochondria are particularly important for skeletal muscle function given the high oxidative demands imposed by intermittent contraction.
“Mitochondria are particularly important for skeletal muscle function, given the high oxidative demands imposed on this tissue by intermittent contraction.”
The paper relies on this without support.
Healthy muscle tissue predominantly oxidizes lipid in the fasting state and transitions to carbohydrate oxidation during the fed state.
“For example, healthy muscle tissue predominantly oxidizes lipid in the fasting state, as evidenced by low respiratory quotient (RQ), with subsequent tran-sition to carbohydrate oxidation (increased RQ) during the fed state.”
The paper relies on this without support.
OXPHOS gene expression is coordinately regulated.
“Additionally, because OXPHOS gene expression is coordinately regulated, patterns of differential OXPHOS expression may be more readily detectable in disease states, yet not necessarily mirror other aspects of mitochondrial oxidative capacity.”
The paper relies on this without support.
Changes in the levels of OXPHOS and other oxidative genes must occur in response to cellular energetic and metabolic needs, and in a coordinated manner that ensures the stoichiometric assembly of the products of distinct genes into functional complexes.
“Changes in the levels of OXPHOS and other oxidative genes must occur in response to cellular energetic and metabolic needs, and in a coordinated manner that ensures the stoichiometric assembly of the products of distinct genes into functional complexes.”
The paper relies on this without support.
Coordination of OXPHOS gene expression in muscle is mediated in part by the action of coactivators and corepressors.
“As in other tissues, the coordination of OXPHOS gene expression in muscle is mediated in part by the action of coactivators and corepressors.”
The paper relies on this without support.
Brown adipocyte mitochondria contain high levels of CPT1b, which is critical for the entry of fatty acids into the mitochondria for β-oxidation.
“Thus, brown adipocyte mitochondria also contain high levels of CPT1b, which is critical for the entry of fatty acids into the mitochondria for -oxidation.”
The paper relies on this without support.
β-Oxidation generates large amounts of reducing equivalents for the ETC.
“-Oxidation, in turn, generates large amounts of reducing equivalents for the ETC.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
T2DM and GDM are associated with a reduced number and function of mitochondria within skeletal muscle cells.
“Separate to insulin sensitivity, T2DM and GDM are associated with a reduced number and function of mitochondria within skeletal muscle cells [126].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [126]
Section 3, “Evidence for reduced muscle mitochondrial oxidative function in DM” (page not provided), reports reduced skeletal-muscle mitochondrial oxidative activity and suggests reduced mitochondrial mass or density in type 2 diabetes. It does not establish a reduced mitochondrial number, and the passages found do not address gestational diabetes (GDM). (LLM, conf=0.88)
Experimental — accuracy not yet measuredObesity and T2DM are associated with mitochondrial dysfunction indicated by low expression of mtDNA and reduction of OXPHOS proteins in rodents and humans.
“In several of the models studied including rodents and humans, these diseases are associated with mitochondrial dysfunction indicated by low expression of mtDNA and reduction of the levels of proteins involved in oxidative phosphorylation (OXPHOS).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Patti and Corvera, 2010
Mitochondrial dysfunction has been described in muscle, liver and adipose tissue during ageing and metabolic syndrome.
“Thus, mitochondrial dysfunction has been described in the main organs involved in the development of metabolic syndrome during ageing such as muscle, liver and adipose tissue (Patti and Corvera, 2010).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Patti and Corvera, 2010
Deficiency in mitochondrial activity in muscle is associated with obesity and T2DM.
“On the other hand, deficiency in mitochondrial activity in muscle is associated with obesity and T2DM.”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Patti and Corvera, 2010
Mitochondrial dysfunction has been described in the main organs involved in the development of metabolic syndrome during ageing such as muscle, liver and adipose tissue.
“mitochondrial dysfunction has been described in the main organs involved in the development of metabolic syndrome during ageing such as muscle, liver and adipose tissue (Patti and Corvera, 2010).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Patti and Corvera, 2010
In several models including rodents and humans, obesity and T2DM are associated with mitochondrial dysfunction indicated by low expression of mtDNA and reduction of levels of proteins involved in OXPHOS.
“In several of the models studied including rodents and humans, these diseases are associated with mitochondrial dysfunction indicated by low expression of mtDNA and reduction of the levels of proteins involved in oxidative phosphorylation (OXPHOS).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Patti and Corvera, 2010
Skeletal muscle cells from obese humans show decreased mitochondrial activity.
“Finally, we evaluated whether Paribs could improve acquired defects in mitochondrial function, such as the decreased mitochondrial activity observed in skeletal muscle cells of obese humans (Patti and Corvera, 2010).”
From Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle (2014) · cites this paper as Patti and Corvera, 2010
Cites
1 retracted
Southgate, R. J., Bruce, C. R., Carey, A. L., Steinberg, G. R., Walder, K., Monks, R., Watt, M. J., Hawley, J. A., Birnbaum, M. J., & Febbraio, M. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3993fje · Cited by 74 · see citing works
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720 · see citing works
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399 · see citing works
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Smit, E. (2003) · Human Kinetics eBooks · doi:10.5040/9781718206601.ch-001 · Cited by 4,382 · see citing works
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · see citing works
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · see citing works
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452 · see citing works
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165 · see citing works
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · see citing works
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901 · see citing works
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · see citing works
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · see citing works
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · see citing works
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468 · see citing works
PRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347 · see citing works
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · see citing works
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · see citing works
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · see citing works
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123 · see citing works
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · see citing works
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · see citing works
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S.-E., Walford, G. A., Sugiana, C., Boneh, A., Chen, W. K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.016 · Cited by 1,994 · see citing works
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · see citing works
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · see citing works
Self-citationHigh Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult Humans
Saito, M., Okamatsu-Ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-Kobayashi, J., Iwanaga, T., Miyagawa, M., Kameya, T., Nakada, K., et al. (2009) · Diabetes · doi:10.2337/db09-0530 · Cited by 1,848 · see citing works
Unexpected evidence for active brown adipose tissue in adult humans
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00691.2006 · Cited by 1,824 · see citing works
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666 · see citing works
Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
Larsson, N.-G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., & Clayton, D. A. (1998) · Nature Genetics · doi:10.1038/ng0398-231 · Cited by 1,594 · see citing works
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · see citing works
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482 · see citing works
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho‐Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,467 · see citing works
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368 · see citing works
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · see citing works
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277 · cited 1× · see citing works
“Risk factors for the development of and/or progression of type 2 DM include: 1) genetics (10–16), exemplified by the high risk of type 2 DM in particular ethnic groups (17) and the high concordance rates in monozygotic twin pairs (18); and 2) both prenatal and postnatal environmental factors, including suboptimal intr…”
BackgroundHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · see citing works
Transcriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · see citing works
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · see citing works
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169 · see citing works
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., Rosner, B., Hennekens, C. H., Speizer, F. E., Rimm, E. B., & Krolewski, A. S. (1991) · The Lancet · doi:10.1016/0140-6736(91)90664-b · Cited by 1,164 · see citing works
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162 · see citing works
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · see citing works
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · see citing works
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107 · see citing works
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096 · see citing works
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017 · see citing works
Projection of Diabetes Burden Through 2050
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004 · cited 1× · see citing works
“6 million new cases diagnosed in adults in 2007 (2) and a projected increase of 165% from 2000 to 2050 (4).”
BackgroundLuft, R., Ikkos, D., Palmieri, G. M. A., Ernster, L., & Afzelius, B. A. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104637 · Cited by 981 · see citing works
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974 · see citing works
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951 · see citing works
Zhang, C.-Y., Baffy, G., Perret, P., Krauss, S., Peroni, O., Grujic, D., Hagen, T., Vidal-Puig, A. J., Boss, O., Kim, Y.-B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00378-6 · Cited by 917 · see citing works
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · see citing works
Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889 · see citing works
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887 · see citing works
The role of mitochondria in reactive oxygen species metabolism and signaling
Starkov, A. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.015 · Cited by 846 · see citing works
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 834 · see citing works
Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212754200 · Cited by 832 · see citing works
Virbasius, J. V., & Scarpulla, R. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1309 · Cited by 819 · see citing works
Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · see citing works
Morino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · see citing works
The biosynthesis and functional role of cardiolipin
Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810 · see citing works
The Burden of Mortality Attributable to Diabetes
Roglić, G., Unwin, N. C., Bennett, P. H., Mathers, C. D., Tuomilehto, J. O., Nag, S., Connolly, V. M., & King, H. O. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2130 · Cited by 809 · see citing works
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807 · see citing works
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753 · see citing works
The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic Consequences
de Ferranti, S. D., & Mozaffarian, D. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.100156 · Cited by 734 · see citing works
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734 · see citing works
Timmons, J. A., Wennmalm, K., Larsson, O., Walden, T. B., Lassmann, T., Petrovic, N., Hamilton, D. L., Gimeno, R. E., Wahlestedt, C., Baar, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610615104 · Cited by 732 · see citing works
Zingaretti, M. C., Crosta, F., Vitali, A., Guerrieri, M., Frontini, A., Cannon, B., Nedergaard, J., & Cinti, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-133546 · Cited by 725 · see citing works
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ
ZURLO, F., Lillioja, S., Puente, A. E.-D., Nyomba, B. L. G., Raz, I., Saad, M. F., Swinburn, B. A., Knowler, W. C., Bogardus, C., & Ravussin, É. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.5.e650 · Cited by 704 · see citing works
Arany, Z., He, H., Lin, J., Hoyer, K., Handschin, C., Toka, O., Ahmad, F., Matsui, T., Chin, S., Wu, P.-H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.002 · Cited by 694 · see citing works
Mootha, V. K., Handschin, C., Arlow, D., Xie, X., St. Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401401101 · Cited by 688 · see citing works
Newsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L. O., Procopio, J., Morgan, D., Oliveira‐Emilio, H. C., Carpinelli, A. R., & Curi, R. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.135871 · Cited by 684 · see citing works
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682 · see citing works
Cardiovascular risk factors emerge after artificial selection for low aerobic capacity.
Wisløff, U., Najjar, S. M., Ellingsen, Ø., Haram, P. M., Swoap, S., Al-Share, Q., Fernström, M., Rezaei, K., Lee, S. J., Koch, L. G., et al. (2005) · Science · doi:10.1126/science.1108177 · Cited by 657 · see citing works
Jacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1113 · Cited by 643 · see citing works
Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1926 · Cited by 629 · cited 1× · see citing works
“Reduced OXPHOS gene expression has been observed in response to genetic and nutritional obesity (127), short-term high-fat feeding (even in humans) (128), lipid infusion (129), and lipid loading of myotubes (127).”
BackgroundPoulsen, P., Kyvik, K. O., Vaag, A. A., & Beck‐Nielsen, H. (1999) · Diabetologia · doi:10.1007/s001250051131 · Cited by 617 · see citing works
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617 · see citing works
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616 · see citing works
Self-citationHandschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., LeBrasseur, N. K., Yan, Z., & Spiegelman, B. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704817200 · Cited by 611 · see citing works
Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density.
Barrès, R., Osler, M. E., Yan, J., Rune, A., Fritz, T., Caidahl, K., Krook, A., & Zierath, J. R. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.011 · Cited by 602 · see citing works
Maturation of Iron-Sulfur Proteins in Eukaryotes: Mechanisms, Connected Processes, and Diseases
Lill, R., & Mühlenhoff, U. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162653 · Cited by 595 · see citing works
Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes
Himms-Hagen, J., Melnyk, A., Zingaretti, M. C., Ceresi, E., Barbatelli, G., & Cinti, S. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c670 · Cited by 593 · see citing works
Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.075 · Cited by 592 · see citing works
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578 · see citing works
Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573 · see citing works
How Obesity Causes Diabetes: Not a Tall Tale
Lazar, M. A. (2005) · Science · doi:10.1126/science.1104342 · Cited by 570 · see citing works
Abdominal obesity as important component of insulin-resistance syndrome.
Després, J. (1994) · PubMed · Cited by 568 · see citing works
Lin, J., Puigserver, P., Donovan, J., Tarr, P., & Spiegelman, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100631200 · Cited by 552 · see citing works
A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.
Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y.-I., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301403 · Cited by 551 · see citing works
Birthweight and the Risk for Type 2 Diabetes Mellitus in Adult Women
Rich-Edwards, J. W., Colditz, G. A., Stampfer, M. J., Willett, W. C., Gillman, M. W., Hennekens, C. H., Speizer, F. E., & Manson, J. E. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4_part_1-199902160-00005 · Cited by 544 · see citing works
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538 · see citing works
Emerging functions of mammalian mitochondrial fusion and fission
Chen, H., & Chan, D. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi270 · Cited by 538 · see citing works
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.3.351 · Cited by 530 · see citing works
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519 · see citing works
Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
Hertz, R., Magenheim, J., Berman, I., & Bar‐Tana, J. (1998) · Nature · doi:10.1038/33185 · Cited by 509 · see citing works
Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression.
Wright, D. C., Han, D.-H., Garcia-Roves, P. M., Geiger, P. C., Jones, T. E., & Holloszy, J. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606116200 · Cited by 488 · see citing works
Stump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332551100 · Cited by 477 · see citing works
Acquirement of brown fat cell features by human white adipocytes
Tiraby, C., Tavernier, G., Lefort, C., Larrouy, D., Bouillaud, F., Ricquier, D., & Langin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305235200 · Cited by 474 · see citing works
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469 · see citing works
Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo
Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1392 · Cited by 467 · see citing works
Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K., Leszyk, J., Nicoloro, S., Czech, M., & Corvera, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1085-1094.2003 · Cited by 459 · see citing works
Self-citationBefroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453 · see citing works
Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S.-H., Pandey, A., & Puigserver, P. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.013 · Cited by 443 · see citing works
Simoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441 · see citing works
Anderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440 · see citing works
Maassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s103 · Cited by 439 · see citing works
Wang, J., Wilhelmsson, H., Graff, C., Li, H., Oldfors, A., Rustin, P., Brüning, J. C., Kahn, C. R., Clayton, D. A., Barsh, G. S., et al. (1999) · Nature Genetics · doi:10.1038/5089 · Cited by 435 · see citing works
Silva, J. P., Köhler, M., Graff, C., Oldfors, A., Magnuson, M. A., Berggren, P.-O., & Larsson, N.-G. (2000) · Nature Genetics · doi:10.1038/81649 · Cited by 433 · see citing works
Nakamura, S., Takamura, T., Matsuzawa-Nagata, N., Takayama, H., Misu, H., Noda, H., Nabemoto, S., Kurita, S., Ota, T., Ando, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901488200 · Cited by 426 · see citing works
Parone, P. A., Da Cruz, S., Tondera, D., Mattenberger, Y., James, D. I., Maechler, P., Barja, F., & Martinou, J.-C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003257 · Cited by 415 · see citing works
Heilbronn, L. K., Smith, S. R., & Ravussin, É. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802853 · Cited by 411 · see citing works
The efficiency and plasticity of mitochondrial energy transduction.
Brand, M. D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330897 · Cited by 406 · see citing works
Pospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404 · see citing works
Russell, L. K., Mansfield, C. M., Lehman, J. J., Kovacs, A., Courtois, M., Saffitz, J. E., Medeiros, D. M., Valencik, M. L., McDonald, J. A., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000117088.36577.eb · Cited by 402 · see citing works
Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., Lewis, G. D., Vasan, R. S., Carr, S. A., Thadhani, R., Gerszten, R. E., & Mootha, V. K. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.50 · Cited by 399 · see citing works
Fatty Acid Regulation of Gene Transcription
Duplus, E., Glorian, M., & Forest, C. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000015200 · Cited by 395 · see citing works
Nishikawa, T., & Araki, E. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1458 · Cited by 391 · see citing works
Nishino, N., Tamori, Y., Tateya, S., Kawaguchi, T., Shibakusa, T., Mizunoya, W., Inoue, K., Kitazawa, R., Kitazawa, S., Matsuki, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34090 · Cited by 388 · see citing works
Calvo, J. A., Daniels, T. G., Wang, X., Paul, A., Lin, J., Spiegelman, B. M., Stevenson, S. C., & Rangwala, S. M. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01231.2007 · Cited by 377 · see citing works
Mitochondrial dynamics and division in budding yeast
Shaw, J. M., & Nunnari, J. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02246-2 · Cited by 375 · see citing works
Andersson, U., & Scarpulla, R. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3738-3749.2001 · Cited by 374 · see citing works
Arany, Z., Lebrasseur, N., Morris, C., Smith, E., Yang, W., Ma, Y., Chin, S., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.003 · Cited by 370 · see citing works
Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α.
Luo, J., Sladek, R., Carrier, J., Bader, J.-A., Richard, D., & Giguère, V. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.7947-7956.2003 · Cited by 370 · see citing works
Nuclear receptor corepressor RIP140 regulates fat accumulation
Leonardsson, G., Steel, J. H., Christian, M., Pocock, V., Milligan, S., Bell, J., So, P.-W., Medina-Gomez, G., Vidal-Puig, A., White, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401013101 · Cited by 366 · see citing works
Mitochondria are impaired in the adipocytes of type 2 diabetic mice.
Choo, H.-J., Kim, J.-H., Kwon, O.-B., Lee, C. S., Mun, J. Y., Han, S. S., Yoon, Y.-S., Yoon, G., Choi, K.-M., & Ko, Y.-G. (2006) · Diabetologia · doi:10.1007/s00125-006-0170-2 · Cited by 365 · see citing works
Simoneau, J., Colberg, S. R., Thaete, F. L., & Kelley, D. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781930 · Cited by 362 · cited 2× · see citing works
“oxidase (COX) activity in the fasting state (107, 108) and”
BackgroundMitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion
Leloup, C., Tourrel-Cuzin, C., Magnan, C., Karaca, M., Castel, J., Carneiro, L., Colombani, A.-L., Ktorza, A., Casteilla, L., & Pénicaud, L. (2009) · Diabetes · doi:10.2337/db07-1056 · Cited by 361 · see citing works
Kamei, Y., Ohizumi, H., Fujitani, Y., Nemoto, T., Tanaka, T., Takahashi, N., Kawada, T., Miyoshi, M., Ezaki, O., & Kakizuka, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135217100 · Cited by 357 · see citing works
Soriano, F. X., Liesa, M., Bach, D., Chan, D. C., Palacín, M., & Zorzano, A. (2006) · Diabetes · doi:10.2337/db05-0509 · Cited by 343 · see citing works
Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., & Yki–Järvinen, H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.021 · Cited by 339 · see citing works
Rong, J. X., Qiu, Y., Hansen, M. K., Zhu, L., Zhang, V., Xie, M., Okamoto, Y., Mattie, M. D., Higashiyama, H., Asano, S., et al. (2007) · Diabetes · doi:10.2337/db06-1135 · Cited by 335 · see citing works
Handschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J., Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31785 · Cited by 335 · see citing works
Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter
Miller, W. L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.012 · Cited by 332 · see citing works
Lai, L., Leone, T. C., Zechner, C., Schaeffer, P. J., Kelly, S. M., Flanagan, D. P., Medeiros, D. M., Kovacs, A., & Kelly, D. P. (2008) · Genes & Development · doi:10.1101/gad.1661708 · Cited by 326 · see citing works
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324 · see citing works
Foxo1 integrates insulin signaling with mitochondrial function in the liver
Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J. T., Depinho, R. A., Puigserver, P., & White, M. F. (2009) · Nature Medicine · doi:10.1038/nm.2049 · Cited by 321 · see citing works
Claypool, S. M., Oktay, Y., Boontheung, P., Loo, J. A., & Koehler, C. M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801152 · Cited by 318 · see citing works
The biochemistry of an inefficient tissue: brown adipose tissue.
Cannon, B., & Nedergaard, J. (1985) · PubMed · Cited by 309 · see citing works
Petersen, K. F., Dufour, S., & Shulman, G. I. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020233 · Cited by 308 · see citing works
Jacobsson, A., Stadler, U., Glotzer, M. A., & Kozak, L. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36228-2 · Cited by 300 · see citing works
Ling, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J. F. P., Beck‐Nielsen, H., Groop, L., & Vaag, A. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421889 · Cited by 300 · see citing works
Ling, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300 · see citing works
Vaag, A., Henriksen, J. E., & Beck-Nielsen, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115656 · Cited by 299 · cited 1× · see citing works
“Indeed, multiple metabolic defects have been observed in muscle from insulin-resistant but normoglycemic subjects at high risk for diabetes development, including: 1) reduced insulin-stimulated glycogen synthesis (27, 91, 92); 2) alterations in insulin signal transduction (93); and 3) increased muscle lipid accumulati…”
BackgroundGranneman, J. G., Li, P., Zhu, Z., & Lu, Y. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00009.2005 · Cited by 298 · see citing works
Physiological diversity of mitochondrial oxidative phosphorylation
Benard, G., Faustin, B., Passerieux, E., Galinier, A., Rocher, C., Bellance, N., Delage, J.-P., Casteilla, L., Letellier, T., & Rossignol, R. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00195.2006 · Cited by 297 · see citing works
Osman, C., Haag, M., Potting, C., Rodenfels, J., Dip, P. V., Wieland, F., Brügger, B., Westermann, B., & Langer, T. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200810189 · Cited by 295 · see citing works
Lelliott, C. J., Medina-Gomez, G., Petrovic, N., Kis, A., Feldmann, H. M., Bjursell, M., Parker, N., Curtis, K., Campbell, M., Hu, P., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040369 · Cited by 280 · see citing works
Choi, C. S., Befroy, D. E., Codella, R., Kim, S., Reznick, R. M., Hwang, Y.-J., Liu, Z.-X., Lee, H.-Y., Distefano, A., Samuel, V. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810339105 · Cited by 279 · see citing works
Essential role of mitochondrial function in adiponectin synthesis in adipocytes
Koh, E. H., Park, J.-Y., Park, H.-S., Jeon, M. J., Ryu, J. W., Kim, M., Kim, S. Y., Kim, M.-S., Kim, S.-W., Park, I. S., et al. (2007) · Diabetes · doi:10.2337/db07-0510 · Cited by 275 · see citing works
Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis
Hance, N., Ekstrand, M. I., & Trifunovic, A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi184 · Cited by 272 · see citing works
Nuclear Control of Respiratory Chain Expression in Mammalian Cells
Scarpulla, R. C. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022681828846 · Cited by 269 · see citing works
Toh, S. Y., Gong, J., Du, G., Li, J. Z., Yang, S., Ye, J., Yao, H., Zhang, Y., Xue, B., Li, Q., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002890 · Cited by 267 · see citing works
Sonoda, J., Mehl, I. R., Chong, L.-W., Nofsinger, R. R., & Evans, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611623104 · Cited by 266 · see citing works
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
Ducluzeau, P., Peretti, N., Laville, M., Andréelli, F., Véga, N., Riou, J. P., & Vidal, H. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1134 · Cited by 263 · see citing works
Richardson, D. K., Kashyap, S., Bajaj, M., Cusi, K., Mandarino, S. J., Finlayson, J., DeFronzo, R. A., Jenkinson, C. P., & Mandarino, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408985200 · Cited by 259 · see citing works
A role for the transcriptional coactivator PGC-1α in muscle refueling.
Wende, A. R., Schaeffer, P. J., Parker, G. J., Zechner, C., Han, D.-H., Chen, M. M., Hancock, C. R., Lehman, J. J., Huss, J. M., McClain, D. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707006200 · Cited by 257 · cited 2× · see citing works
“(265) results in increased mitochondrial density and a ro-”
BackgroundGene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
Sreekumar, R., Halvatsiotis, P., Schimke, J. C., & Nair, K. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1913 · Cited by 257 · see citing works
Genetic Factors in Type 2 Diabetes: The End of the Beginning?
O’Rahilly, S., Barroso, I., & Wareham, N. J. (2005) · Science · doi:10.1126/science.1104346 · Cited by 252 · see citing works
Mitochondrial uncoupling as a target for drug development for the treatment of obesity.
Harper, J. A., Dickinson, K., & Brand, M. D. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00043.x · Cited by 250 · see citing works
Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number
Tyynismaa, H., Sembongi, H., Bokori-Brown, M., Granycome, C., Ashley, N., Poulton, J., Jalanko, A., Spelbrink, J. N., Holt, I. J., & Suomalainen, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh342 · Cited by 250 · see citing works
Garcia-Roves, P., Huss, J. M., Han, D.-H., Hancock, C. R., Iglesias-Gutierrez, E., Chen, M., & Holloszy, J. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704024104 · Cited by 246 · see citing works
Bouillaud, F., Ricquier, D., Thibault, J., & Weissenbach, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.445 · Cited by 244 · see citing works
PGC-1β in the Regulation of Hepatic Glucose and Energy Metabolism
Lin, J., Tarr, P. T., Yang, R., Rhee, J., Puigserver, P., Newgard, C. B., & Spiegelman, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303643200 · Cited by 242 · cited 1× · see citing works
“Up-regulation of PGC-1 in this context may contribute to increased gluconeogenesis and hyperlipidemia, in part via coactivation of sterol regulatory element binding transcription factor 1, as observed in high-fat diet-fed mice (223).”
BackgroundDistinct genomic copy number in mitochondria of different mammalian organs.
Veltri, K. L., Espiritu, M., & Singh, G. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041430122 · Cited by 242 · see citing works
Ultrastructure of the Mitochondrion and Its Bearing on Function and Bioenergetics
Bénard, G., & Rossignol, R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2000 · Cited by 240 · see citing works
Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611214200 · Cited by 236 · cited 3× · see citing works
“that genetic background (127), age at dietary intervention,”
BackgroundSelf-citationPowelka, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26040 · Cited by 236 · see citing works
Leick, L., Wojtaszewski, J. F. P., Johansen, S. T., Kiilerich, K., Comes, G., Hellsten, Y., Hidalgo, J., & Pilegaard, H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00666.2007 · Cited by 236 · see citing works
Rapid transformation of white adipocytes into fat-oxidizing machines
Orci, L., Cook, W. S., Ravazzola, M., Wang, M.-Y., Park, B.-H., Montesano, R., & Unger, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308258100 · Cited by 234 · see citing works
Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status
Bruce, C. R., Anderson, M. J., Carey, A. L., Newman, D. G., Bonen, A., Kriketos, A. D., Cooney, G. J., & Hawley, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030791 · Cited by 234 · see citing works
Chibalin, A. V., Leng, Y., Vieira, E., Krook, A., Björnholm, M., Long, Y. C., Kotova, O., Zhong, Z., Sakane, F., Steiler, T., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.035 · Cited by 232 · see citing works
Fat content in individual muscle fibers of lean and obese subjects.
Malenfant, P., Joanisse, D., Thériault, R., Goodpaster, B., Kelley, D., & Simoneau, J.-A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801733 · Cited by 227 · see citing works
Recent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 218 · see citing works
Kaaman, M., Sparks, L. M., van Harmelen, V., Smith, S. R., Sjölin, E., Dahlman, I., & Arner, P. (2007) · Diabetologia · doi:10.1007/s00125-007-0818-6 · Cited by 217 · see citing works
Benton, C. R., Nickerson, J. G., Lally, J., Han, X.-X., Holloway, G. P., Glatz, J. F. C., Luiken, J. J. F. P., Graham, T. E., Heikkila, J. J., & Bonen, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704332200 · Cited by 214 · see citing works
Mitochondrial protein-import machinery: correlating structure with function
Baker, M. J., Frazier, A. E., Gulbis, J. M., & Ryan, M. T. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.010 · Cited by 213 · see citing works
Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ.
Cinti, S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344046 · Cited by 213 · see citing works
Semple, R. K., Crowley, V. C., Sewter, C. P., Laudes, M., Christodoulides, C., Considine, R. V., Vidal-Puig, A., & O'Rahilly, S. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802482 · Cited by 203 · see citing works
Simmons, R. A., Suponitsky-Kroyter, I., & Selak, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505695200 · Cited by 194 · see citing works
The Transcriptional Corepressor RIP140 Regulates Oxidative Metabolism in Skeletal Muscle
Seth, A., Steel, J. H., Nichol, D., Pocock, V., Kumaran, M. K., Fritah, A., Mobberley, M. A., Ryder, T. A., Rowlerson, A. M., Scott, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.004 · Cited by 189 · see citing works
Hwang, J.-H., Stein, D. T., Barzilai, N., Cui, M.-H., Tonelli, J., Kishore, P., & Hawkins, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2006 · Cited by 188 · see citing works
Convertible adipose tissue in mice.
Lončar, D. (1991) · Cell and Tissue Research · doi:10.1007/bf00678721 · Cited by 187 · see citing works
Nair, K. S., Bigelow, M. L., Asmann, Y. W., Chow, L. S., Coenen-Schimke, J. M., Klaus, K. A., Guo, Z.-K., Sreekumar, R., & Irving, B. A. (2008) · Diabetes · doi:10.2337/db07-1556 · Cited by 187 · see citing works
Dahlman, I., Forsgren, M., Sjögren, A., Nordström, E. A., Kaaman, M., Näslund, E., Attersand, A., & Arner, P. (2006) · Diabetes · doi:10.2337/db05-1421 · Cited by 184 · see citing works
Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance.
Vianna, C. R., Huntgeburth, M., Coppari, R., Choi, C. S., Lin, J., Krauss, S., Barbatelli, G., Tzameli, I., Kim, Y.-B., Cinti, S., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.003 · Cited by 181 · see citing works
Skeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175 · see citing works
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle.
Rönn, T., Poulsen, P., Hansson, O., Holmkvist, J., Almgren, P., Nilsson, P., Tuomi, T., Isomaa, B., Groop, L., Vaag, A., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1018-8 · Cited by 175 · see citing works
A Drosophila model of Barth syndrome
Xu, Y., Condell, M., Plesken, H., Edelman‐Novemsky, I., Ma, J., Ren, M., & Schlame, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603242103 · Cited by 174 · see citing works
Rampersaud, E., Damcott, C. M., Fu, M., Shen, H., McArdle, P., Shi, X., Shelton, J., Yin, J., Chang, Y.-P. C., Ott, S. H., et al. (2007) · Diabetes · doi:10.2337/db07-0457 · Cited by 170 · see citing works
Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle
Sreekumar, R., Unnikrishnan, J., Fu, A., Nygren, J., Short, K. R., Schimke, J., Barazzoni, R., & Nair, K. S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00387.2001 · Cited by 170 · see citing works
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works
Supramolecular organization of protein complexes in the mitochondrial inner membrane
Vonck, J., & Schäfer, E. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.019 · Cited by 168 · see citing works
Thyroid hormone-related regulation of gene expression in human fatty liver.
Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164 · see citing works
Self-citationPi, J., Bai, Y., Daniel, K. W., Liu, D., Lyght, O., Edelstein, D., Brownlee, M., Corkey, B. E., & Collins, S. (2009) · Endocrinology · doi:10.1210/en.2008-1642 · Cited by 163 · see citing works
Lehman, J. J., Boudina, S., Banke, N. H., Sambandam, N., Han, X., Young, D. M., Leone, T. C., Gross, R. W., Lewandowski, E. D., Abel, E. D., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00081.2008 · Cited by 158 · see citing works
Flagged first, then by citations
2 of the 297 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611 · see citing works
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874 · see citing works
“Separate to insulin sensitivity, T2DM and GDM are associated with a reduced number and function of mitochondria within skeletal muscle cells [126].”
BackgroundMitochondrial electron transport chain, ROS generation and uncoupling (Review)
Zhao, R., Jiang, S., Zhang, L., & Yu, Z. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4188 · Cited by 1,415 · see citing works
Incalza, M. A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,375 · see citing works
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258 · see citing works
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923 · see citing works
Reactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824 · see citing works
Mitochondrial reactive oxygen species drive proinflammatory cytokine production
Naik, E., & Dixit, V. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110367 · Cited by 783 · see citing works
Arruda, A. P., Pers, B. M., Parlakgül, G., Güney, E., Inouye, K., & Hotamışlıgil, G. S. (2014) · Nature Medicine · doi:10.1038/nm.3735 · Cited by 716 · see citing works
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 600 · see citing works
What causes the insulin resistance underlying obesity?
Hardy, O. T., Czech, M. P., & Corvera, S. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283514e13 · Cited by 563 · see citing works
Self-citationMitochondrial dysfunction in obesity
de Mello, A. H., Costa, A. B., Engel, J. D. G., & Rezin, G. T. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.11.019 · Cited by 508 · see citing works
Schapira, A. H. V. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61305-6 · Cited by 499 · see citing works
Hosomi, K., Saito, M., Park, J., Murakami, H., Shibata, N., Ando, M., Nagatake, T., Konishi, K., Ohno, H., Tanisawa, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32015-7 · Cited by 467 · see citing works
Chlorinated Persistent Organic Pollutants, Obesity, and Type 2 Diabetes
Lee, D., Porta, M. S., Jacobs, D. R., & Vandenberg, L. N. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1084 · Cited by 420 · see citing works
Pharmacological approaches to restore mitochondrial function
Andreux, P. A., Houtkooper, R. H., & Auwerx, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4023 · Cited by 383 · see citing works
Mitochondrial dysfunction in white adipose tissue
Kusminski, C. M., & Scherer, P. E. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.004 · Cited by 368 · see citing works
Ma, X., Xu, L., Alberobello, A. T., Gavrilova, O., Bagattin, A., Skarulis, M. C., Liu, J., Finkel, T., & Mueller, E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.005 · Cited by 337 · see citing works
Cellular metabolic and autophagic pathways: Traffic control by redox signaling
Dodson, M. B., Darley-Usmar, V. M., & Zhang, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.014 · Cited by 325 · see citing works
Oxidative Stress in Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Bana, M. A., Tinkov, A. A., Saad, K., Dadar, M., Hemimi, M., Skalny, A. V., Hosnedlová, B., Kizek, R., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01742-2 · Cited by 323 · see citing works
Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
Meza, C. A., La Favor, J. D., Kim, D.-H., & Hickner, R. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153775 · Cited by 323 · see citing works
Wu, S., Lu, Q., Ding, Y., Wu, Y., Qiu, Y., Wang, P., Mao, X., Huang, K., Xie, Z., & Zou, M.-H. (2019) · Circulation · doi:10.1161/circulationaha.118.033552 · Cited by 298 · see citing works
Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis
Giordano, A., Murano, I., Mondini, E., Perugini, J., Smorlesi, A., Severi, I., Barazzoni, R., Scherer, P. E., & Cinti, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038638 · Cited by 297 · see citing works
Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine‐tune hypoxic mitophagy
Chen, Z., Liu, L., Cheng, Q., Li, Y., Wu, H., Zhang, W., Wang, Y., Sehgal, S. A., Siraj, S., Wang, X., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643309 · Cited by 295 · see citing works
Development of insulin resistance in mice lacking PGC-1α in adipose tissues
Kleiner, S., Mepani, R. J., Laznik, D., Li, Y., Jurczak, M. J., Jornayvaz, F. R., Estall, J. L., Bhowmick, D. C., Shulman, G. I., & Spiegelman, B. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207287109 · Cited by 286 · see citing works
Mitochondrial uncoupling proteins and energy metabolism
Busiello, R. A., Savarese, S., & Lombardi, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00036 · Cited by 259 · see citing works
Pirinen, E., Cantó, C., Jo, Y. S., Morato, L., Zhang, H., Menzies, K. J., Williams, E. G., Mouchiroud, L., Moullan, N., Hagberg, C., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.002 · Cited by 254 · see citing works
“Finally,weevaluatedwhetherParibscould improveacquireddefects in mitochondrial function, such as the decreased mitochondrial activity observed in skeletal muscle cells of obese humans (Patti and Corvera, 2010).”
BackgroundNon-Alcoholic Fatty Liver Disease
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_19 · Cited by 247 · see citing works
Vernochet, C., Mourier, A., Bezy, O., Macotela, Y., Boucher, J., Rardin, M. J., An, D., Lee, K. Y., Ilkayeva, O. R., Zingaretti, C. M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.016 · Cited by 245 · see citing works
Mitochondria and cardiovascular diseases-from pathophysiology to treatment
Siasos, G., Tsigkou, V., Kosmopoulos, M., Theodosiadis, D., Simantiris, S., Tagkou, N. M., Tsimpiktsioglou, A., Stampouloglou, P. K., Oikonomou, E., Mourouzis, K., et al. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.21 · Cited by 245 · see citing works
Attané, C., Foussal, C., Gonidec, S. L., Bénani, A., Daviaud, D., Wanecq, E., Guzmán‐Ruiz, R., Dray, C., Bézaire, V., Rancoule, C., et al. (2011) · Diabetes · doi:10.2337/db11-0100 · Cited by 226 · see citing works
Mitonuclear interactions: evolutionary consequences over multiple biological scales
Wolff, J. N., Ladoukakis, E. D., Enrı́quez, J. A., & Dowling, D. K. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0443 · Cited by 222 · see citing works
Chen, Y., Umanah, G. K. E., Dephoure, N., Andrabi, S. A., Gygi, S. P., Dawson, T. M., Dawson, V. L., & Rutter, J. P. (2014) · The EMBO Journal · doi:10.15252/embj.201487943 · Cited by 217 · see citing works
Adipose tissue angiogenesis: Impact on obesity and type-2 diabetes
Corvera, S., & Gealekman, O. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.003 · Cited by 211 · see citing works
Self-citationLecube, A., Pachón, G., Pétriz, J., Hernández, C., & Simó, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023366 · Cited by 206 · see citing works
Identification of a Protein Mediating Respiratory Supercomplex Stability
Chen, Y.-C., Taylor, E. B., Dephoure, N., Heo, J.-M., Tonhato, A., Papandreou, I., Nath, N., Denko, N. C., Gygi, S. P., & Rutter, J. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.006 · Cited by 205 · see citing works
Tubbs, E., Chanon, S., Robert, M., Bendridi, N., Bidaux, G., Chauvin, M.-A., Ji-Cao, J., Durand, C., Gauvrit-Ramette, D., Vidal, H., et al. (2018) · Diabetes · doi:10.2337/db17-0316 · Cited by 202 · see citing works
Malandrino, M. I., Fucho, R., Weber, M., Calderón‐Domínguez, M., Mir, J. F., Valcárcel-Jiménez, L., Escoté, X., Gómez‐Serrano, M., Peral, B., Salvadó, L., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2014 · Cited by 200 · see citing works
Mitochondrial calcium homeostasis as potential target for mitochondrial medicine
Giorgi, C., Agnoletto, C., Bononi, A., Bonora, M., Marchi, E. D., Marchi, S., Missiroli, S., Patergnani, S., Poletti, F., Rimessi, A., et al. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.07.004 · Cited by 200 · see citing works
Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes
Legrand-Poels, S., Esser, N., L’homme, L., Scheen, A., Paquot, N., & Piette, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.013 · Cited by 194 · see citing works
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 187 · see citing works
Alcalá, M., Calderón‐Domínguez, M., Araya, M. E. B., Ramos, P., Casals, N., Serra, D., Viana, M., & Herrero, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-16463-6 · Cited by 186 · see citing works
Pesta, D. H., Hoppel, F., Macek, C., Messner, H., Faulhaber, M., Kobel, C., Parson, W., Burtscher, M., Schocke, M. F. H., & Gnaiger, E. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00285.2011 · Cited by 181 · see citing works
Fructose: A Key Factor in the Development of Metabolic Syndrome and Hypertension
Khitan, Z. J., & Kim, D. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/682673 · Cited by 181 · see citing works
Yang, X., Liu, Q., Li, Y., Tang, Q., Wu, T., Chen, L., Pu, S., Zhao, Y., Zhang, G., Huang, C., et al. (2020) · Adipocyte · doi:10.1080/21623945.2020.1807850 · Cited by 178 · see citing works
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Byrne, N. J., Rajasekaran, N. S., Abel, E. D., & Bugger, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.046 · Cited by 175 · see citing works
Vernochet, C., Damilano, F., Mourier, A., Bézy, O., Mori, M. A., Smyth, G., Rosenzweig, A., Larsson, N., & Kahn, C. R. (2014) · The FASEB Journal · doi:10.1096/fj.14-253971 · Cited by 170 · see citing works
Unravelling the mechanisms regulating muscle mitochondrial biogenesis
Hood, D. A., Tryon, L. D., Carter, H. N., Kim, Y., & Chen, C. C. W. (2016) · Biochemical Journal · doi:10.1042/bcj20160009 · Cited by 159 · see citing works
He, F., Huang, Y., Song, Z. Q., Zhou, H. J., Zhang, H., Perry, R. J., Shulman, G. I., & Wang, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201416 · Cited by 158 · see citing works
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154 · see citing works
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism
Lerín, C., Goldfine, A. B., Boes, T., Liu, M., Kasif, S., Dreyfuss, J. M., Sousa‐Coelho, A. L. D., Daher, G., Manoli, I., Sysol, J. R., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.08.001 · Cited by 150 · see citing works
Self-citationTedesco, L., Valerio, A., Dossena, M., Cardile, A., Ragni, M., Pagano, C., Pagotto, U., Carruba, M. O., Vettor, R., & Nisoli, E. (2010) · Diabetes · doi:10.2337/db09-1881 · Cited by 149 · see citing works
Energy metabolism of white adipose tissue and insulin resistance in humans
Bódis, K. B., & Roden, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13017 · Cited by 147 · see citing works
Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine
Marcovina, S. M., Sirtori, C. R., Peracino, A. P., Gheorghiade, M., Borum, P. R., Remuzzi, G., & Ardehali, H. (2012) · Translational research · doi:10.1016/j.trsl.2012.10.006 · Cited by 146 · see citing works
Mitochondrial function/dysfunction in white adipose tissue
Boudina, S., & Graham, T. E. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.081414 · Cited by 146 · see citing works
Jin, L. G., Tang, Q., Hu, S., Chen, Z., Zhou, X., Zeng, B., Wang, Y., He, M., Li, Y., Gui, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23560-8 · Cited by 135 · see citing works
Cardamone, M. D., Tanasă, B., Cederquist, C., Huang, J., Mahdaviani, K., Li, W., Rosenfeld, M. G., Liesa, M., & Perissi, V. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.037 · Cited by 134 · see citing works
Fatty acid metabolism and the basis of brown adipose tissue function
Calderón‐Domínguez, M., Mir, J. F., Fucho, R., Weber, M., Serra, D., & Herrero, L. (2015) · Adipocyte · doi:10.1080/21623945.2015.1122857 · Cited by 126 · see citing works
Zheng, L., Linarelli, L. E., Liu, L., Wall, S. S., Greenawald, M. H., Seidel, R. W., Estabrooks, P. A., Almeida, F. A., & Cheng, Z. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0093-1 · Cited by 126 · see citing works
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Hashimoto, Y., Takahashi, F., Okamura, T., Hamaguchi, M., & Fukui, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155585 · Cited by 124 · see citing works
Evidence for the intra-uterine programming of adiposity in later life
Fall, C. H. D. (2011) · Annals of Human Biology · doi:10.3109/03014460.2011.592513 · Cited by 123 · see citing works
Tang, W. H., Stitham, J., Jin, Y., Liu, R., Lee, S. H., Du, J., Atteya, G. A., Gleim, S., Spollett, G. R., Martin, K. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005224 · Cited by 122 · see citing works
Perevoshchikova, I. V., Quinlan, C. L., Orr, A. L., Gerencser, A. A., & Brand, M. D. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.006 · Cited by 120 · see citing works
Joseph, A.-M., Joanisse, D. R., Baillot, R. G., & Hood, D. A. (2011) · Experimental Diabetes Research · doi:10.1155/2012/642038 · Cited by 117 · see citing works
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 117 · see citing works
Crescenzo, R., Bianco, F., Falcone, I., Coppola, P., Liverini, G., & Iossa, S. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0356-y · Cited by 117 · see citing works
Origins of metabolic complications in obesity
Mittendorfer, B. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834ad8b6 · Cited by 116 · see citing works
Kobori, M., Takahashi, Y., Sakurai, M., Akimoto, Y., Tsushida, T., Oike, H., & Ippoushi, K. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500595 · Cited by 111 · see citing works
Exploring the therapeutic space around NAD+
Houtkooper, R. H., & Auwerx, J. H. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201207019 · Cited by 109 · see citing works
Hartman, M.-L., Shirihai, O. S., HOLBROOK, M. M., Xu, G., Kocherla, M., Shah, A. K., Fetterman, J. L., Kluge, M. A., Frame, A. A., Hamburg, N. M., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14521315 · Cited by 109 · see citing works
Inflammatory Signaling and Brown Fat Activity
Omran, F., & Christian, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00156 · Cited by 107 · see citing works
The clinical impact and biological mechanisms of skeletal muscle aging
Aversa, Z., Zhang, X., Fielding, R. A., Lanza, I. R., & LeBrasseur, N. K. (2019) · Bone · doi:10.1016/j.bone.2019.05.021 · Cited by 104 · see citing works
Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity
López-Lluch, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.005 · Cited by 103 · see citing works
“Thus, mitochondrial dysfunction has been described in the main organs involved in the development of metabolic syndrome during ageing such as muscle, liver and adipose tissue (Patti and Corvera, 2010).”
BackgroundRebollo‐Hernanz, M., Zhang, Q., Aguilera, Y., Martin-Cabrejas, M. A., & de Mejı́a, E. G. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110672 · Cited by 103 · see citing works
Iommarini, L., Kurelac, I., Capristo, M., Calvaruso, M. A., Giorgio, V., Bergamini, C., Ghelli, A. M., Nanni, P., Giovanni, C. D., Carelli, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt533 · Cited by 101 · see citing works
The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
Yi, H.-S., Chang, J. Y., & Shong, M. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0005 · Cited by 99 · see citing works
Ji, C., Chen, X., Gao, C., Jiao, L., Wang, J., Xu, G., Fu, H., Guo, X., & Zhao, Y. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9361-8 · Cited by 99 · see citing works
Statins are associated with increased insulin resistance and secretion
Abbasi, F., Lamendola, C., Harris, C. S., Harris, V., Tsai, M.-S., Tripathi, P., Abbas, F., Reaven, G. M., Reaven, P. D., Snyder, M. P., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316159 · Cited by 98 · see citing works
Patterson, J. N., Cousteils, K., Lou, J. W., Manning Fox, J. E., MacDonald, P. E., & Joseph, J. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521666 · Cited by 98 · see citing works
Mitochondrial dysfunction in patients with primary congenital insulin resistance
Sleigh, A., Raymond‐Barker, P., Thackray, K., Porter, D. A., Hatunic, M., Vottero, A., Burren, C. P., Mitchell, C., McIntyre, M., Brage, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46405 · Cited by 95 · see citing works
Hroob, A. M. A., Abukhalil, M. H., Hussein, O. E., & Mahmoud, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.086 · Cited by 95 · see citing works
Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link
Cheng, Z., & Almeida, F. A. (2014) · Cell Cycle · doi:10.4161/cc.28189 · Cited by 94 · see citing works
Kulkarni, S. S., Salehzadeh, F., Fritz, T., Zierath, J. R., Krook, A., & Osler, M. E. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.014 · Cited by 94 · see citing works
Evolutionary perspectives on the links between mitochondrial genotype and disease phenotype
Dowling, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.013 · Cited by 92 · see citing works
Energy balance regulation by endocannabinoids at central and peripheral levels
Quarta, C., Mazza, R., Obici, S., Pasquali, R., & Pagotto, U. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.002 · Cited by 92 · see citing works
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 92 · see citing works
Mitochondrial function in ageing: coordination with signalling and transcriptional pathways
Yin, F., Sancheti, H., Liu, Z., & Cadenas, E. (2015) · The Journal of Physiology · doi:10.1113/jp270541 · Cited by 92 · see citing works
Alam, M. A., & Rahman, M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-60 · Cited by 92 · see citing works
Hafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91 · see citing works
Hayden, M. R. (2019) · Brain Sciences · doi:10.3390/brainsci9100262 · Cited by 90 · see citing works
Targeting Mitochondria in Diabetes
Jakovljevic, N. K., Pavlović, K., Jotić, A., Lalic, K. S., Stoiljkovic, M. M., Lukić, L., Milicic, T. J., Macesic, M. V., Gajović, J. S., & Lalic, N. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126642 · Cited by 90 · see citing works
Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes
Zelezniak, A., Pers, T. H., Soares, S., Patti, M., & Patil, K. R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000729 · Cited by 86 · see citing works
Self-citationDiabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
Sergi, D., Renaud, J., Simola, N., & Martinoli, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00302 · Cited by 85 · see citing works
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 83 · see citing works
Lim, Y., Grimm, A., Giese, M. H., Mensah‐Nyagan, A. G., Villafranca, J. E., Ittner, L. M., Eckert, A., & Götz, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028887 · Cited by 82 · see citing works
Mitochondrial Dysfunction in Age‐Related Metabolic Disorders
Natarajan, V., Chawla, R., Mah, T. K. L., Vivekanandan, R., Tan, S., Sato, P. Y., & Mallilankaraman, K. B. (2020) · PROTEOMICS · doi:10.1002/pmic.201800404 · Cited by 81 · see citing works
Zhang, Z., Ding, Y., Dai, X., Wang, J., & Li, Y. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.033 · Cited by 81 · see citing works
Addinsall, A. B., Wright, C. R., Andrikopoulos, S., van der Poel, C., & Stupka, N. (2018) · Biochemical Journal · doi:10.1042/bcj20170920 · Cited by 79 · see citing works
Wang, M., Liu, H., Zheng, J., Chen, B., Zhou, M., Fan, W., Wang, H., Liang, X., Zhou, X.-L., Eriani, G., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739482 · Cited by 79 · see citing works
Lee, J.-Y., Lee, D., Im, J., & Lee, J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/586017 · Cited by 78 · see citing works
- Authors
- Patti, M.-E., & Corvera, S.
- Affiliations
- Joslin Diabetes Center (US)
- Harvard University (US)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2010-06-01
- Volume
- 31
- Issue
- 3
- Pages
- 364-395
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC3365846
- OpenAlex
- W2166954428
- Cited by
- 551
- References
- 297
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 26 · 2023: 30 · 2022: 32 · 2021: 42 · 2020: 27 · 2019: 38 · 2018: 38 · 2017: 36 · 2016: 40 · 2015: 35 · 2014: 51 · 2013: 39 · 2012: 36
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Joslin Diabetes Center
- National Institutes of Health (DK32520, LM008748, DK 36836)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK080366, DK36836, DK-062948, R21DK080366, DK 32520, P30DK032520, R01DK060837, DK060837, R01DK062948, P30DK036836)
- U.S. National Library of Medicine (U54LM008748, LM 008748)
- National Center for Research Resources (M01RR001032)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes pathogenesis, mitochondrial dysfunction, insulin resistance, oxidative stress, PGC-1, mitochondrial biogenesis, skeletal muscle, adipose tissue, liver, pancreatic beta cells, obesity, overnutrition, lipid peroxidation, energy homeostasis, mitochondrial morphology
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Mitochondria, Oxidative Phosphorylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review